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        Abstract 
CLARE MARKS GIBSON: An investigation of the effects of oxytocin on social cognition and social 
functioning in schizophrenia 
(Under the direction of David L. Penn) 
 
Social functioning is a core feature of schizophrenia, and it is related to outcome and 
disease onset. Social cognitive processes underlie social functioning and as such have been a 
treatment target in schizophrenia; however, psychosocial treatments targeting social cognition are 
often not available in clinics and there are no current psychopharmacological agents that improve 
social cognition or social functioning in schizophrenia. Consequently, there has been great interest in 
oxytocin (OT) as a potential treatment for social cognition in schizophrenia, and as an additive to 
current psychological approaches. OT stimulates prosocial behavior and antipsychotic-like effects in 
animals and humans, and there is preliminary evidence supporting OT’s role in social cognition in 
humans. Therefore, the current study explored whether OT can improve social cognition and social 
functioning in schizophrenia using a six-week, double-blind design. Twenty individuals with 
schizophrenia were randomized to receive either intranasal OT or a saline placebo solution and 
completed a battery of social cognitive measures, as well as measures of social functioning, 
community functioning, neurocognition and psychiatric symptoms. Results showed improvements on 
self-reported cognitive empathy, deception detection, and global social skills in the OT condition as 
compared to the PL condition. In addition, post-hoc analyses demonstrated improved identification of 
intense facial emotions and a reduction in negative symptoms for the OT condition. These 
preliminary findings indicate OT may help improve certain components of social cognition in 
schizophrenia. Implications for the treatment of social functioning in schizophrenia and early 
intervention are discussed.  
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CHAPTER I 
Introduction 
 
This study investigated the effects of oxytocin on social cognition in schizophrenia, 
as well as on community and social functioning. One of schizophrenia’s hallmark features is 
social impairment (Bellack, Morrison, Wixted, & Mueser, 1990), which is related to critical 
disease-related factors, such as relapse (Sullivan, Marder, Liberman, Donahoe, & Mintz, 
1990). Social cognition, our ability to perceive and interpret others’ intentions (Fiske & 
Taylor, 2008), underlies social functioning. Indeed, individuals with schizophrenia show 
impaired social cognition (Penn, Sanna, & Roberts, 2008) and these impairments are 
associated with poor social functioning in schizophrenia (Couture, Penn, & Roberts, 2006). 
Thus, researchers have explored avenues to remediate social cognition.  Since 
pharmacological agents have not appeared to be beneficial in improving social cognition 
(Harvey, Patterson, Potter, Zhong, & Brecher, 2006), psychotherapeutic approaches have 
been developed and show promise (Horan, Kern, Green & Penn, 2008). In light of the 
importance of social functioning in schizophrenia and a paucity of current treatments, there is 
a need to explore other potential therapeutic approaches, such as oxytocin.  
Oxytocin (OT) is a neuropeptide that has been referred to as the “great facilitator of 
life” (Lee, Macbeth, Pagani, & Young, 2009) because of its role in human social behavior.  
OT has recently been applied to psychological disorders where social functioning is 
impaired, such as schizophrenia (Macdonald & Macdonald, 2010); however, there a limited 
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number of published studies evaluating the effects of exogenous OT on social cognition 
(Averbeck, Bobin, Evans, Shergill, 2012; Goldman, Gomes, Carter & Lee, 2011; Pedersen et 
al., 2011) and only one randomized control trial to evaluate daily OT dosing (Pedersen et al., 
2011).  Additionally, no study has evaluated the effects of OT on social and community 
functioning. This current study examined OT’s role in improving social cognition, social 
functioning, and community functioning to elucidate the therapeutic potential of OT for 
schizophrenia.  
The introduction will provide the reader with the most relevant background 
concerning social functioning, social cognition, and oxytocin as they relate to schizophrenia. 
The introduction begins with a review of social functioning and its relationship to such 
variables as prognosis and quality of life. Then, a discussion of the processes that underlie 
social functioning namely, social cognition will be explored. Specifically, the social 
cognitive domains of emotion perception and theory of mind will be highlighted since 
current OT research indicates it has a beneficial impact on these areas. Other areas of social 
cognition, such as empathy, social judgment and attributional style will also be reviewed 
because OT may theoretically have a beneficial impact on these domains. This will lead to a 
broad review of oxytocin, followed by a more focused discussion of oxytocin’s role in social 
cognition in healthy controls, and preliminary evidence of its role in psychological disorders, 
including schizophrenia. The introduction will end with the present study’s aims and 
hypotheses.  
    Social Functioning in Schizophrenia 
Social functioning deficits are a core feature of schizophrenia (Mueser & Bellack, 1998) 
and independent from other features of the illness such as negative and positive symptoms 
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(Bellack et al., 2004). Social functioning is a broad term that refers to a variety of socially 
related behaviors such as interpersonal skills, work and school functioning, and independent 
living skills (Couture et al., 2006). Specifically, individuals with schizophrenia have shown 
worse interpersonal skills (Pinkham & Penn, 2006; Sitzer, Twamley, Patterson, & Jeste, 
2008) and display fewer prosocial behaviors (Brune, Abdel-Hamid, Sonntag, Lehmkamper, 
& Langdon, 2009) compared to non-clinical controls.  In addition, poor social support (e.g., 
lack of contact with family and few friends) is related to prognosis and functioning, such as 
self-care and employment (Erickson, Beiser, Iacono, Fleming, & Lin, 1989; Evert, Harvey, 
Trauer, & Herrman, 2003). 
Social functioning deficits do not appear to be a function of disease onset or chronicity; 
rather they are evident throughout the course of the illness. Addington et al. (2007) found 
social functioning deficits throughout the course of the illness including those in the 
prodrome (i.e., individuals displaying attenuated positive symptoms), and in first and multi-
episode psychosis. Social functioning was also associated with quality of life in each of these 
groups.  Supporting the evidence that social deficits are not necessarily a function of disease 
onset is that attenuated deficits in social behavior are observed in first-degree relatives 
(Dworkin, Lewis, Cornblatt, & Erlenmeyer-Kimling, 1994; Gibson, Penn, Prinstein, Perkins, 
& Belger, 2010; Tarbox & Pogue-Geile, 2008). Thus, evidence suggests social functioning 
could be considered a marker of disease vulnerability and not necessarily a byproduct of 
disease related variables, such as the effects of stigma, medication or institutionalization.  
Researchers have developed a variety of methods to evaluate social functioning in 
schizophrenia. There are three main approaches to this area of research. First, self-report 
measures have been developed (e.g., social functioning scale [SFS];Birchwood, Smith, 
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Cochrane, Wetton, & Copestake, 1990), where participants rate their social functioning. 
Second, informant reports are widely used where a family member or mental health 
professional rates the affected family member’s social behavior (e.g., The Specific Levels of 
Functioning Scale [SLOF]; Schneider & Struening, 1983). Both the self-report and informant 
reports capture overall community functioning, such as daily activities, daily skills, and work 
skills (Mausbach et al., 2010). Third, performance-based measures, such as role-plays are 
used to assess social skills, and are thought to capture functional capacity (Mausbach et al., 
2010). Role-plays typically involve participants engaging in a videotaped conversation with a 
confederate and the participants’ social skills are later evaluated and rated (Mueser & 
Bellack, 1998; Patterson, Goldman, McKibbin, Hughs, & Jeste, 2001).  Objective measures 
such as role-plays are a valuable tool for measuring social behavior in light of research 
suggesting individuals with schizophrenia lack insight into their social skill deficits (Mueser 
& Bellack, 1998) and more generally have poor metacognitive abilities (Kircher, Koch, 
Stottmeister, & Durst, 2007). Performance-based tools are also associated with community 
functioning assessments. Mausbach et al. (2010), for example, assessed individuals with 
schizophrenia and bipolar disorder with a role-play measure and a community functioning 
assessment, the SLOF. Better role-play performance was related to both greater residential 
independence and informant ratings on the SLOF. Therefore, performance-based measures 
are a valid assessment of real-world functioning and alleviate the potential confound of poor 
insight and bias found in self-reports.   
The aforementioned measures are not unique to schizophrenia research, but are used to 
evaluate social functioning in other disorders (e.g., Mausbach et al., 2010). While social 
functioning deficits are observed in a variety of psychiatric disorders (e.g., Autism; Baron-
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Cohen & Wheelwright, 2003; e.g., Depression; Erickson et al., 1989; e.g., Bipolar Disorder; 
Mausbach, et al., 2010), these social difficulties are more compromised and have shown to 
play a critical role in outcome in schizophrenia. Mausbach et al. (2010) found individuals 
with schizophrenia had worse functional and community functioning scores compared to 
individuals with bipolar disorder. Additionally, research evaluating social functioning and 
schizophrenia has highlighted the importance of this area as valuable in elucidating disease 
trajectory and as a treatment target. The role of social functioning as a target for early 
intervention is highlighted by the findings that social functioning is a robust a predictor of 
disease outcome (Addington et al., 2007; Niendam, Jalbrzikowski, & Bearden, 2009) and a 
predictor of disease onset (Cannon et al., 2008). Additionally, social functioning, such as 
availability of acquaintances has been a predictor of outcome in those with chronic 
schizophrenia (Evert et al., 2003; Erickson et al., 1989) and better social functioning is 
related to increased therapeutic alliance (Couture et al., 2006).  Thus, social functioning is an 
essential area to target in schizophrenia as it is both related to outcome and relapse.  
The relationship between social functioning and outcome has prompted researchers to 
evaluate treatments targeting social functioning. Since antipsychotics do not appear to 
improve social functioning (Bellack et al., 2004; Heinssen, Liberman, & Kopelowicz, 2000), 
a variety of psychological treatments aimed at improving social functioning have been 
developed and are efficacious at improving social functioning in schizophrenia (Granholm et 
al., 2005; Kurtz & Mueser, 2008; Roberts & Penn, 2009). Kurtz and Mueser’s (2008) meta-
analysis of social skills interventions in schizophrenia demonstrated moderate to large effect 
sizes for performance-based measures (e.g., role plays of social interactions), daily living 
skills and community functioning.  Thus, interventions targeted at social skills demonstrate 
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social functioning is amenable to improvement; however, while social skills interventions for 
schizophrenia often include elements to facilitate generalization of skills (Kopelowicz, 
Liberman, & Zarate, 2006; Kurtz & Mueser, 2008), social interactions may be too nuanced 
and complex to fully address in social skills training. That is, social skills interventions for 
schizophrenia tend to focus more of specific skills (e.g., eye contact) but not on the 
underlying processes that might enhance skill generalization across a variety of social 
situations.  
Social Cognition 
One area that has received recent attention as a possible mechanism underlying social 
deficits in schizophrenia is social cognition. Social cognition refers to our ability to 
understand others intentions, beliefs, and emotions (Fiske & Taylor, 2008) and has been 
studied extensively in humans, as well as primates (Silk, 2007). The Social Brain hypothesis 
is consistent with an evolutionary basis of social cognition, where it is hypothesized that our 
brains have evolved to navigate complex social interactions and larger brain size is 
associated with increased social networks in primates (Dunbar, 2009).  
Indeed, social cognition is related to social functioning in schizophrenia in that intact 
social cognition (e.g., the ability to understand what another person is thinking) facilitates 
social relationships and is related to social functioning (Addington, Saeedi, & Addington, 
2006; Baslet, Termini, & Herbener, 2009; Bora, Eryavuz, Kayahan, Sungu, & Veznedaroglu, 
2006; Pinkham & Penn, 2006; Zhu, et al., 2007). For reviews see Couture et al. (2006) and 
Fett et al. (2010). Furthermore, Pinkham and Penn (2006) found social cognition to be the 
strongest predictor of social functioning in schizophrenia. Similar to social functioning, 
current antipsychotics do not appear to improve social cognition (Penn et al., 2009). Overall, 
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these findings suggest that social cognitive processes underlie social functioning and are 
critical to the ability to effectively interact in the social world.  
Although there is no definitive empirical consensus regarding the domains that constitute 
social cognition, a few domains have been theoretically proposed.  Specifically, the major 
domains of social cognition in schizophrenia include emotion processing, theory of mind, 
social perception, and attributional style (Green, Olivier, Crawley, Penn, & Silverstein, 2005; 
Green et al., 2008; Penn et al., 2008). Emotion processing refers to the ability to identify and 
understand emotions in oneself and others (Green et al., 2008). Emotion processing is 
utilized in behaviors such as emotion recognition and empathy. Theory of Mind (ToM) is the 
ability to infer another person’s mental or affective state and is critical to effective social 
functioning (Roncone et al., 2002). Social perception involves the integration of social 
information to inform judgments made about one’s social world; for example the degree to 
which one may find another trustworthy. Attributions refer to the causal inferences one 
makes about a situation or event (Bentall, Kaney, & Dewey, 1991; Green, et al., 2008; 
Kinderman, Kaney, Morley, & Bentall, 1992). As Green et al. (2008) point out, social 
cognitive abilities are not mutually exclusive, per se, but rather there is a great deal of 
overlap; for instance, theory of mind may include an affective perspective-taking 
component—such that it becomes an integration of emotion recognition and theory of mind. 
Each of the components of social cognition will be discussed in more detail later in the 
introduction.  
The importance of social cognition in improving social functioning is highlighted by the 
evidence suggesting social cognition accounts for a greater proportion of variance in social 
functioning compared to neurocognition (Couture, Penn, et al., 2006; Fett et al., 2010; Penn, 
!  
 
 *
!
Corrigan, Bentall, Racenstein, & Newman, 1997). In a recent meta-analysis, Fett et al. (2010) 
found that social cognition explained more variance in community functioning compared to 
neurocognition.  Specifically, social cognition explained 16 percent and neurocognition six 
percent of the variation in functional outcome. The functional outcome variables in their 
meta-analysis included community functioning (e.g. work and social functioning), social 
problem solving (e.g., ability to generate solutions to daily social occurrences) and social 
skills (as measured by role plays). When Fett et al. controlled for potential moderators such 
as gender, age, illness chronicity, and inpatient status, there was no effect on the relationship 
between social cognition and functional outcome, although these moderators slightly 
mitigated the relationship between neurocognition and functional outcome. Fett et al. 
recommend that more research should evaluate the relationship between social cognition, 
neurocognition and social skills and social problem solving, since a majority of the studies 
found in their review focused predominately on community functioning.  
In the next section, I will review the specific components of social cognition as measured 
in schizophrenia research. Specific attention will be paid to areas of social cognition that are 
most integral to research on oxytocin and social cognition in schizophrenia, namely emotion 
perception and theory of mind, as they have received the greatest amount of attention in the 
literature.  Furthermore, there is preliminary evidence oxytocin can improve functioning in 
these areas. Other domains of social cognition that have not received the same amount of 
attention will be discussed, namely empathy, social perception (e.g., trustworthiness), and 
attributional style. These domains will be explored since they are theoretically related to 
oxytocin, and there is preliminary research demonstrating oxytocin can improve these areas 
of social cognition.  
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Emotion Recognition 
Emotion recognition is well studied in schizophrenia, specifically facial emotion 
recognition. (For reviews see Chan, Li, Cheung, & Gong, 2010; Kohler, Walker, Martin, 
Healey, & Moberg, 2009; Marwick & Hall, 2008; Morris, Weickert, & Loughland, 2009). 
Meta-analyses and narrative reviews indicate individuals with schizophrenia have worse 
facial emotion perception in schizophrenia compared to healthy controls. Other areas of 
emotion perception, such as vocal emotion recognition are also impaired (for a meta-analysis 
see Hoekert, Kahn, Pijnenborg, & Aleman, 2007). Chan et al.’s (2010) meta-analysis found 
large effect sizes for emotion perception in schizophrenia, which were higher than control 
tasks such as overall face and age recognition deficits. Additionally, facial emotion 
recognition deficits appears to be specific to emotionally laden stimuli; for instance 
(Schneider et al., 2006) found individuals with schizophrenia performed worse on a facial 
emotion recognition task compared to more difficult non-emotional tasks (e.g., age 
discrimination). Thus, facial emotion perception does not appear to be a generalized 
cognitive deficit, but is specific to emotion recognition.  
The facial emotion recognition measures are similar across studies. Participants are 
shown facial stimuli and asked to guess the emotion displayed. One of the first and most 
widely used measures of facial emotion recognition is the Facial Emotion Identification Task 
(FEIT; Kerr & Neale, 1993); however the FEIT is limited in ethnicity (i.e., the stimuli are all 
Caucasian faces), which could be problematic because of evidence of a same-race emotion 
bias seen in emotion perception in schizophrenia (Pinkham et al., 2008). More recent 
emotion recognition measures, such as the Penn Emotion Recognition 40 (ER-40) display a 
variety of ethnically diverse faces that express one of four basic emotions: happy, sad, angry, 
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fear, as well as neutral faces. The ER-40 has showed high-levels of test-retest reliability in 
schizophrenia samples and does not show ceiling effects (Carter, Barch, Gur, Pinkham, & 
Ochsner, 2009), which is often a cited problem in tests of emotion recognition (Kohler & 
Martin, 2006) measures.  
Emotion perception is critical to effective social interactions and overall social 
functioning. Poor affect recognition is related to worse social functioning in schizophrenia 
(Addington et al., 2006; Couture, Penn, et al., 2006; Pan, Chen, Chen, & Liu, 2009) and 
worse interpersonal skills (Pinkham & Penn, 2006). Meyer and Kurtz (2009) found affect 
perception was a stronger predictor of social skills than neurocognition. Interestingly, 
emotion perception deficits are not limited to individuals with chronic schizophrenia, but are 
also seen in individuals experiencing their first-episode (FE) of psychosis (Addington et al., 
2006; Edwards, Pattison, Jackson, & Wales, 2001; Pinkham et al., 2005), individuals in the 
prodrome (Addington, Penn, Woods, Addington, & Perkins, 2008; Addington et al., 2006), 
and is similarly related to social functioning deficits at these early stages of illness 
(Addington, et al., 2006).  There is also evidence of emotion perception deficits in the 
unaffected first-degree relatives (Li, Chan, Zhao, Hong, & Gong, 2010). 
 In addition, negative emotions such as fear and anger appear to be more difficult to 
identify (Marwick & Hall, 2008; Morris et al., 2009) and could be related to anxiety when 
looking at faces in schizophrenia (Morris et al., 2009). Additionally, individuals high in 
negative symptoms have displayed worse emotion perception (Chan, et al., 2010; Strauss, 
Jetha, Ross, Duke, & Allen, 2010). There are even neurological correlates with emotion 
misidentification; for example, Gur et al. (2007) found greater amygdalar activation was 
associated with incorrect identification of angry and fearful faces in individuals with 
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schizophrenia compared to a healthy control sample, where increased amygdalar activation 
was related to improved fear identification. In addition, increased amygdalar response to 
fearful facial stimuli was associated with flat affect. 
 Aside from disrupted limbic activation, poor emotion recognition is linked to decreased 
efficiency in scan paths such that individuals with schizophrenia do not attend to critical 
facial features such as the eye and mouth region (Combs et al., 2008; Morris et al., 2009). 
Similar restricted scanning of emotion-laden faces is observed in first-degree relatives 
(Loughland, Williams, & Harris, 2004). Furthermore, interventions targeted at training 
individuals with schizophrenia to focus attention to critical facial features (i.e., the center 
region of the face) have shown to be efficacious (Combs, Chapman, Waguspack, Basso, & 
Penn, 2010).   
Theory of Mind 
Theory of Mind (ToM) is the ability to infer another person’s mental state and is 
important for effective social functioning (Roncone et al., 2002). Reviews indicate 
individuals with schizophrenia have poor ToM (e.g., Bora, Yucel, & Pantelis, 2009; Sprong, 
Schothorst, Vos, Hox, & van Engeland, 2007) and ToM deficits are observed throughout the 
course of the illness (Bora et al., 2009). Frith (2004) argues that there is heterogeneity in 
ToM deficits in schizophrenia, such that those with negative symptoms may have a true ToM 
deficit, and those with predominately positive symptoms have a ToM, but they “over-
mentalize.” That is, Frith argues that individuals high in positive symptoms (e.g., paranoia) 
have a theory of mind and an ability to hypothesize about another’s intentions, but they make 
erroneous conclusions (e.g., paranoid thinking such as the other person is thinking about a 
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plan to harm them).  Frith notes this difficulty with mentalizing naturally leads to social 
discomfort and social withdrawal.  
The construct of ToM has been divided into social perceptual and social cognitive 
components (Sabbagh, 2004), as well as affective and cognitive components (Shamay-
Tsoory, Shur, Barcai-Goodman, et al., 2007). The cognitive components of ToM are thought 
to depend on underlying cognitive processes, which require mentalizing about other’s beliefs 
and intentions. Social perceptual ToM relies on more automatic perceptual abilities, and 
involves mentalizing about the emotional states of others. The affective component of ToM 
similarly requires mentalizing about emotional states (i.e., affective perspective-taking) 
versus beliefs (Shamay-Tsooray et al., 2007). There is neurological research supporting these 
distinctions between ToM components; for example different areas of the brain are evoked 
when performing social perceptual versus cognitive ToM tasks (Shamay-Tsoory, Aharon-
Peretz, & Levkovitz, 2007). Additionally, individuals with schizophrenia have shown worse 
performance on the affective component of ToM as compared to the cognitive component 
(Shamay-Tsoory, Shur, Barcai-Goodman, et al., 2007). Thus, it is prudent to consider and 
evaluate ToM as a multidimensional rather than a unitary construct.  
There are well-established ToM measures, which are routinely applied to 
schizophrenia samples. The cognitive ToM measures generally tap into the ability to 
successfully complete picture sequencing tasks and answer questions about the beliefs of the 
characters in the stories. These tasks evaluate higher orders of ToM (e.g., second order theory 
of mind, where a participant is asked to imagine what another person is thinking about 
someone else). One frequently used picture-sequencing measure, The Brune Task (Brune, 
2003), involves arranging a series of cards into a logical sequence and then answering 
!  
 
 ,%!
!
questions about the characters’ mental states. Individuals with schizophrenia have shown 
worse performance on cognitive ToM measures (Brune, 2005) compared to healthy controls. 
Although there is clearly a cognitive load to such tasks, differences between schizophrenia 
and healthy controls remain on ToM tasks even after controlling for cognitive variables, such 
as executive functioning (Brune, 2005).  
Social perceptual and affective ToM measures involve perceiving the affective states 
of others. Although social perceptual and affective ToM converges on emotion perception, 
research indicates these ToM components are independent of general emotion recognition 
(Kington, Jones, Watt, Hopkin, & Williams, 2000). One highly cited social perceptual and 
affective measure, The Reading the Mind in the Eyes Test or the Eyes Test (Baron-Cohen, 
Wheelwright, Hill, Raste, & Plumb, 2001) is often used in the schizophrenia literature (e.g., 
Bora, et al., 2006; Bora, Gokcen, & Veznedaroglu, 2008; de Achaval, et al., 2010; Shur, 
Shamay-Tsoory, & Levkovitz, 2008). Compared to healthy controls, individuals with 
schizophrenia perform worse on the Eyes Test (Bora et al., 2006; de Achaval et al., 2010; 
Irani et al., 2006; Kelemen et al., 2005; Kelemen, Keri, Must, Benedek, & Janka, 2004). 
ToM deficits on the Eyes Test are observed in first-episode psychosis (Kettle, O'Brien-
Simpson, & Allen, 2008) and in unaffected first-degree relatives (Irani et al., 2006). Kelemen 
et al. (2005) tested ToM in remitted medicated and unmedicated participants and found no 
difference in performance between these groups. Thus, it seems ToM deficits are not a result 
of years of illness or medication, and could be considered a disease-related endophenotype.  
Some studies have found a significant relationship between worse performance on 
ToM tasks and increased negative symptoms (Kelemen, et al., 2005). Shamay-Tsoory, Shur, 
Barcai-Goodman et al. (2007) found negative symptoms were more closely related to 
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performance on an affective ToM measure than a cognitive ToM measure.  Interestingly, the 
Eyes Test and negative symptoms were found to be the most robust predictors of social 
functioning in Bora et al. (2006), although negative symptoms and the Eyes Test were not 
correlated with one another. Bora et al. suggest negative symptoms and ToM may have 
separate yet significant associations with social functioning. These findings are consistent 
with those who have found ToM is associated with social skills (Brune, 2005; Couture et al., 
2006); and others who found ToM to be one of the social cognitive variables most related to 
functioning (Fett et al., 2010).  
Empathy  
 Empathy is another area of social cognition that has received recent attention in 
schizophrenia research (Lee, Farrow, Spence, & Woodruff, 2004). Leiberg and Anders 
(2006, p. 419) define empathy as the “ability to accurately perceive and understand another 
person’s emotions and react appropriately.” Similar to ToM, empathy taps into the broader 
affective (i.e., an emotional experience) and cognitive (i.e., affective perspective taking) 
domains of emotional processing (Decety & Jackson, 2004). Empathy is related to social 
functioning in schizophrenia (Baslet et al., 2009) and less empathy is associated with 
negative symptoms (Bora et al., 2008; Shamay-Tsoory, Shur, Barcai-Goodman, et al., 2007). 
 The most widely used measure in the empathy and schizophrenia literature is the 
Interpersonal Reactivity Index (IRI; Davis, 1983). The IRI is a 28-item self-report measure, 
which uses a five-point likert scale tapping into the affective and cognitive dimensions of 
empathy. The IRI comprises four subscales: Empathic Concern (e.g., feelings of compassion 
and concern for others), Perspective Taking (e.g., taking the viewpoint of other people), 
Fantasy (e.g., a tendency to relate to characters in movies and books) and Personal Distress 
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(e.g., anxiety as a result of other people’s distress).  
 Individuals with schizophrenia have demonstrated empathic difficulties, such as lower 
empathic concern on the IRI compared to healthy controls (Shamay-Tsoory, Shur, Harari, & 
Levkovitz, 2007), and lower self-reported affective perspective-taking ability as compared to 
healthy controls (Haker & Rossler, 2009; Montag, Heinz, Kunz, & Gallinat, 2007; Shamay-
Tsoory, Aharon-Peretz, et al., 2007). The majority of the studies have found increased self-
reported personal distress in response to other’s emotional experiences (Derntl, et al., 2009; 
Haker & Rossler, 2009; Montag, et al., 2007). Thus, there is some evidence that individuals 
with schizophrenia appear able to self-reflect on their empathic deficits; however, Derntl et 
al. (2009) found that empathic deficits were more impaired when using behavioral tasks of 
empathy (i.e., they implemented a task where participants chose the emotion that a person 
would most likely feel in a variety of scenarios) as compared to the self-report measure. 
Derntl et al. (2009) argue that while self-report measures provide some information about 
empathy, using only self-report measures of empathy is limiting. This suggests that self-
reported empathy in schizophrenia should be supplemented with other measurement 
strategies.  
 Another way empathy has been studied is via imitative paradigms (i.e., where 
participants’ ability to mimic another’s behavior is assessed). These paradigms are based on 
research demonstrating that simulation of other’s emotional states is a mechanism for feeling 
empathy and demonstrating concern to others (Decety & Jackson, 2004). Individuals with 
schizophrenia show significantly lower imitative abilities compared to healthy controls 
(Haker & Rossler, 2009; Park, Matthews, & Gibson, 2008). And, decreased contagion 
behavior has been related to decreased levels of self-reported empathy on the IRI (Haker & 
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Rossler, 2009).  
 Thus, there is evidence of empathic deficits in schizophrenia, and greater levels of 
distress in response to others’ emotional states are experienced in this clinical population; 
however, there appears to be some indication that self-report measures of empathy are 
limiting when used in isolation and without other measurement approaches. Given empathy’s 
role in forging relationships with others and the evidence for disrupted empathic processing 
in schizophrenia, this is a valuable area to assess further and perhaps target in treatment.    
Social perception: Evaluation of trustworthiness 
Social perception is another area of social cognition underling social functioning. 
Social perception involves using verbal and nonverbal information to make inferences or 
judgments about social information (Green et al., 2005). Social perception is a broad domain 
that includes a variety of social inferences one may make, including inferences about a 
person, situation, or social role based on the available social cues. As Green et al. (2005) 
explain, social perception converges on emotion perception, but the focus is slightly 
different; for example an emotion perception task may require one to indicate how someone 
feels, whereas a social perceptual measure may require one to infer what series of events 
would have lead a person to feel a particular way.  
Individuals with schizophrenia have shown social perceptual abnormalities (Baas, 
van't Wout, Aleman, & Kahn, 2008; Couture, Penn, Addington, Woods, & Perkins, 2008; 
Penn, Ritchie, Francis, Combs, & Martin, 2002). Specifically, Penn et al. (2002) found that 
individuals with schizophrenia did not use contextual cues (e.g., the title of social scenes) in 
making social judgments (e.g., correctly sequencing the social scenes). Furthermore, failure 
to use contextual cues was related to impaired social behavior on the ward, such as social 
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competence and social interest in Penn et al. (2002). Indeed, poor social perception is related 
to a variety of functional outcomes, such as worse social problem solving (Couture et al., 
2006) and social perception appears to mediate the relationship between neurocognition and 
functional outcome (Couture et al., 2006).  This suggests that social perception is an integral 
component of everyday functioning.  
There are a variety of social perceptual measures; however, for the purpose of the 
current study, I focused on one measure that is particularly pertinent to oxytocin research, 
namely the Trustworthiness Task (Adolphs et al., 1998). As will be discussed later, 
trustworthiness judgments are influenced by intranasal oxytocin (Kosfeld, Heinrichs, Zak, 
Fischbacher, & Fehr, 2005) and oxytocin levels seem to be related to trustworthiness in 
schizophrenia (Keri, Kiss, & Kelemen, 2009).  Overall, trustworthiness tasks require 
individuals to assess the level of trustworthiness of a series of facial stimuli (i.e., the degree 
to which they either trust or distrust the face shown). The Trustworthiness Task (Adolphs et 
al., 1998) displays facial stimuli where participants rate trustworthiness on a scale from 
negative three (very untrustworthy) to positive three (very trustworthy). Making such 
trustworthiness judgments not only requires immediate perception of the stimuli, but also 
accessing past experiences with people or situations similar to the presented stimuli.  
 On trustworthiness measures, some have found a bias to rate untrustworthy faces 
(i.e., faces rated as untrustworthy by healthy controls) as trustworthy in schizophrenia (Bass 
et al., 2008; Couture et al., 2008). Additionally, this bias is not better accounted for by poor 
facial recognition (Bass et al., 2008). Although it is somewhat surprising that untrustworthy 
versus trustworthy faces are perceived differently than healthy controls in individuals with 
schizophrenia, some have noted this could be related to fact that positive affect is easier to 
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detect (Bass et al., 2008). Additionally, similar social judgment biases have been observed in 
first-degree relatives (Bass et al., 2008) and individuals in the schizophrenia prodrome 
(Couture et al., 2008). Such findings indicate that social perception is another area of social 
cognition that appears to be trait and not state-related.  
It should be noted that some have also found a bias in rating the normed trustworthy 
versus untrustworthy faces (Pinkham, Hopfinger, Pelphrey, Piven, & Penn, 2008a; Pinkham, 
Hopfinger, Ruparel, & Penn, 2008b) particularly for subgroups of individuals with 
predominately paranoid symptoms. Pinkham et al. (2008a) and Pinkham et al. (2008b) found 
that individuals with predominately paranoid symptoms rated faces as more untrustworthy 
than participants with fewer positive symptoms and healthy controls. Additionally, Pinkham 
et al. (2008a) found reduced amygdalar activation in the paranoid schizophrenia sample 
when rating untrustworthy faces as compared to healthy controls and the non-paranoid 
schizophrenia sample, and reduced amygdalar activation was related to worse social 
functioning. These findings are consistent with studies assessing trustworthiness judgments 
in individuals with bilateral amygdala damage (Adolphs et al., 1998), where trustworthiness 
biases are also observed. Pinkham et al. (2008a) hypothesize that abnormal amygdalar 
activation may be related to impaired trustworthiness judgments in schizophrenia.  
Related research has found poor social perception in individuals high in persecutory 
delusions (Haut & Macdonald, 2010). Haut and MacDonald (2010) did not find differences 
in trustworthiness ratings when comparing a schizophrenia and healthy control sample, but 
patients higher in persecutory delusions were less likely to use social information, such as 
attractiveness in assessing trustworthiness compared to healthy controls and patients lower in 
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persecutory delusions. This is consistent with Penn et al. (2002) who also found individuals 
with schizophrenia did not use contextual cues in forming social judgments.  
Attributional Style 
Lastly, attributional style was investigated in the current study. Attributional style 
refers to the reasons one makes for the causes of a situation, and is widely studied in a variety 
of psychological disorders (e.g., Depression; Alloy, Peterson, Abramson, & Seligman, 1984; 
Joiner, 2001). Studies have shown that healthy controls tend to demonstrate what is referred 
to as a self-serving bias. That is, causal attributions tend to be “self-serving” in that negative 
life events are attributed to external factors (e.g., “I failed the exam because he is not a good 
teacher”), while positive life events are attributed to internal factors (e.g. “I passed the exam 
because I am proficient in this subject matter”)  (Campbell & Sedikides, 1999).  
Attributional style has been of great interest to schizophrenia researchers because of 
its association with symptoms, such as paranoia (An et al., 2010; Bentall, Corcoran, Howard, 
Blackwood, & Kinderman, 2001; Martin & Penn, 2002). Individuals with increased paranoia 
are more likely to demonstrate an exaggeration of the self-serving bias (Bentall et al., 2001). 
Furthermore, when external attributions are broken down into personal (e.g., an individual 
purposefully caused an event) and situational (e.g., a situation was caused accidentally) 
factors, individuals with schizophrenia show a tendency towards external-personal 
attributions (i.e., “personalizing bias”; Kinderman & Bentall, 1997), which may function to 
preserve one’s self-image (Bentall et al., 2001). A reliance on external attributions is related 
to persecutory delusions as it reinforces beliefs that others are causing one harm and cannot 
be trusted (Bentall et al., 2001; Kinderman & Bentall, 1997). Indeed Aakre, Seghers, St-
Hilaire, & Docherty (2009) found paranoid patients were more likely to use external-personal 
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attributions in explaining negative events compared to patients who did not currently have 
paranoid delusions. Lastly, as has been noted earlier, social cognitive domains are not 
mutually exclusive but have a degree of overlap. Bentall and Kinderman (1998) have argued 
that poor ToM interferes with the ability for individuals with schizophrenia to make 
situational attributions. This assertion is supported by empirical data; for example, Randall, 
Corcoran, Day, & Bentall (2003) found that ToM was a predictor of making more external 
attributions in schizophrenia. Therefore it seems that improving ToM could also have an 
effect on attributional style in schizophrenia. 
There are a variety of measures of attributional style in schizophrenia (e.g., the 
Ambiguous Intentions Hostility Questionnaire, Combs et al. 2007; the Internal Personal and 
Situational Attributions Questionnaire; Kinderman & Bentall, 1996; the Attributional Style 
Questionnaire, Peterson et al., 1982). These measures present participants with hypothetical 
scenarios where they have to discern the causes of the events. On the Attributional Style 
Questionnaire (ASQ; Peterson et al., 1982) and the Internal Personal and Situational 
Attributions Questionnaire (IPSAQ; Kinderman & Bentall, 1996), participants rate whether 
the event was caused by them or another person in the scenario (external-internal dimension). 
The IPSAQ further evaluates whether the cause is perceived as external-personal or external-
situational. Studies have shown discrepancies between the ratings of participants and 
independent raters (e.g., individuals with schizophrenia have indicated their causes of 
negatives events are related to internal factors, while independent raters score them as 
external attributions; Martin & Penn, 2002; Randall et al., 2003). In addition to such 
discrepancies, there have been issues concerning the reliability and validity of these 
instruments (Bentall, et al., 2001).  
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A recent measure, the Ambiguous Intentions Hostility Questionnaire (AIHQ; Combs 
et al. 2007) has sound psychometric properties and is a promising new measure of 
attributional style in schizophrenia. Similar to other attributional measures, participants 
indicate the causes of a variety of situations that have occurred to them. They also indicate 
what they would do about the situations. The situations, however, vary in the intentionality, 
where some are accidental, intentional or ambiguous. Participants rate whether the person 
acted a certain way to them on purpose, how angry it would make them feel and how much 
they would blame the other person (these three ratings yield a “blame score”).  Independent 
raters score the degree of hostility in the causal responses and aggression in how they would 
approach the scenario. The AIHQ is unique in that it assesses hostility and includes 
ambiguous situations, which are not found on the ASQ or IPSAQ. It is critical to assess 
hostility in schizophrenia because individuals with paranoia have shown to identify hostility 
in situations where hostility is not evident (Combs, et al., 2009) and the use of ambiguous 
situations rather than just intentional events is more likely to tap into social cognitive biases. 
Indeed, individuals who are high in paranoia are more apt to perceive threat in ambiguous 
situations (Combs et al., 2007). The inclusion of ambiguous situations also bolsters the 
AIHQ’s external validity as many of the daily interactions that one experiences are 
ambiguous, and do not have definitive closure (e.g., people laughing as you walk by). Thus, 
attributional style is more comprehensively measured by evaluating not only locus of control, 
but hostility and aggression in ambiguous situations.  
Individuals with schizophrenia, particularly those with greater persecutory delusions, 
have shown a hostility bias as measured by the AIHQ (Combs et al., 2009). In Combs et al. 
(2009), the attributional style in individuals high in persecutory delusions (PDs) was 
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compared to those without PDs. The PD group demonstrated a personalizing bias such that 
they had more hostility and blame attributions to ambiguous situations and hostility bias was 
a significant predictor of paranoia. The AIHQ appears sensitive enough to detect treatment 
effects in schizophrenia; for example following eighteen weeks of Social Cognitive 
Interaction Training (SCIT), participants had significantly lower hostility and blame subscale 
scores on the AIHQ compared to before treatment, as well as compared to individuals in the 
treatment control group (Combs et al., 2007).  
Consistent with other areas of social cognition, the aforementioned attributional 
biases are evident throughout the course of the illness. Similar attributional style has been 
observed in the prodrome and first-episode (FE) psychosis (An et al., 2010). Interestingly, in 
An et al. (2010), FE and prodromal individuals both showed a hostility bias on the AIHQ 
compared to healthy controls, and the prodromal individuals had a significantly higher blame 
bias (i.e., blaming other for negative outcomes) than the FE group and healthy controls. In 
the FE and prodromal groups, hostility bias was related to paranoia, and blame was related to 
level of paranoia in the prodromal group. Further support for attributional style as a 
vulnerability marker comes from the research not only showing an external attributional style 
in first-degree of individuals with schizophrenia, but also that it is a predictor of future 
psychosis onset (Frenkel, Kugelmass, Nathan, & Ingraham, 1995).   
Less work has been conducted on the relationship between social functioning and 
attributional style, but there is tentative data on this relationship (Couture et al., 2008); for 
example, external attributional style has been linked to aggressive behavior in inpatients with 
schizophrenia (Waldheter et al., 2005). Lysker et al. (2004) found that attributional style, 
specifically perceiving life events as unstable and unpredictable, was related to worse social 
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functioning in individuals with schizophrenia. Lastly, a personalizing bias is related to 
insecure attachment styles in schizophrenia (Donohoe, et al., 2008). In light of the evidence 
that attributional style contributes to paranoia, and is possibly related to social functioning 
and ToM, it is certainly a promising area to target in treatment.  
Summary and Implications of Social Cognition and Schizophrenia Research 
 In summary, individuals with schizophrenia have marked difficulties in social 
functioning, which are associated with outcome and relapse. Due to social functioning’s 
impact on schizophrenia, it is essential to evaluate more proximal underlying processes, such 
as social cognition. Individuals with schizophrenia have shown deficits and biases in a 
variety of social cognitive domains including emotion identification, theory of mind, 
empathy, social perception, and attributional style. Social cognitive deficits are observed 
across the course of the illness, as well as in first-degree relatives. Therefore, these deficits 
are not necessarily a byproduct of medication or disease chronicity, but are more likely 
associated with disease vulnerability. In addition, social cognitive impairments in 
schizophrenia are strongly related to social functioning beyond other variables such as 
neurocognition. These findings underscore the importance of social cognition as a treatment 
target.  
  A variety of efforts have been put forth to improve social cognition.  While 
pharmacological approaches have not shown efficacious in remediating social cognitive 
deficits (Harvey et al., 2006; Penn et al., 2009), psychosocial approaches have been 
developed with the ultimate goal of improving social functioning (Green et al., 2008; Horan 
et al., 2008; Kern et al., 2009). Kern et al.’s (2009) review of psychosocial approaches in 
schizophrenia highlights the benefits of treatments that focus on social cognition. However, 
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they also point out there are no current medications that similarly improve social cognition or 
social functioning in schizophrenia. As Kern et al. suggest, pharmacological agents can be 
useful for initiating engagement in psychotherapy and augmenting its benefits. Additionally, 
some facilities may not have the resources to properly train clinicians in psychological 
approaches for individuals with schizophrenia, so pharmacological approaches targeting 
social cognition could be of great utility in community clinics. Thus, there is a need for 
pharmacological agents that could be used to facilitate improvements in social cognition and 
social functioning. One such pharmacological agent is oxytocin.  The next section will 
provide an overview of oxytocin, as well as evidence of its role in social behavior and its 
potential use in schizophrenia. This review will include research in non-human mammals, 
humans, and preliminary evidence of its effects on social cognition in non-clinical 
populations and clinical populations, including schizophrenia.  
Oxytocin 
Oxytocin: Background and Basic Research 
Oxytocin (OT) is a neuropeptide associated with social behavior, such as empathy, 
attachment, trust and affiliation (Lee, Macbeth, Pagani, & Young, 2009). OT is found 
throughout the central nervous system and is highly concentrated in the paraventricular and 
supraoptic nuclei of the hypothalamus (Carter, Boone, Pournajafi-Nazarloo, & Bales, 2009). 
OT is most commonly known for its uterine contraction and lactation properties (Insel, 
Young, Wang, 1997) and is implicated in a variety of social behaviors, such as maternal 
behavior (Pedersen, Ascher, Monroe, & Prange, 1982), emotion recognition, understanding 
other’s mental states, empathy, social affiliation, as well as other behaviors such as anxiety 
and depression (Lee et al., 2009). There also appears to be gender differences in OT levels, 
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where some have found that OT expression is higher in females (Carter, 2007; Yamasue, 
Kuwabara, Kawakubo, & Kasai, 2009).    
Animal models of OT, specifically prairie voles, provide much of what we know 
about the effects of OT on behavior (Carter, Williams, Witt, & Insel, 1992). Prairie voles are 
often used as models of human social behavior because they are monogamous and display 
biparental behavior patterns (Carter et al., 2009; Carter et al., 1992). Animal research has 
shown that levels of OT are related to maternal behavior, where increased OT expression 
throughout the rat brain is related to increased maternal behavior, such as grooming pups 
(Lee et al., 2009). Increased OT in plasma is even observed in expectant mice fathers during 
pregnancy (Gubernick, Winslow, Jensen, Jeanotte, & Bowen, 1995). In prairie voles, OT is 
involved in mate bonding and increased social contact and exploration of new situations 
(Carter, et al., 1992).  
Interestingly, early experiences (i.e., prenatal and postnatal stages) have implications 
for later parenting and OT levels (e.g., Carter, Boone, et al., 2009; Pedersen & Boccia, 2002). 
In rats, prenatal stress is related to OT levels in offspring (Carter et al. 2009). Additionally, 
Carter et al. (2009) discuss a series of studies where prairie voles were disrupted after the 
offspring were born (e.g., the voles were moved to different cages in a cup). This disruption 
was related to later decreased levels of OT in the male offspring, and decreased parental 
behavior. When OT was directly manipulated in the postnatal stage, such that newborn voles 
were given either OT or an OT antagonist, the OT males had more pair bonding; whereas, the 
OT antagonist voles had decreased parental behavior (e.g., not attending to vole pups). 
Critically, Carter et al. (2009) note that the effects of the OT antagonist and high postnatal 
family disruption can be reversed; for example, when the voles who were administered the 
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OT antagonist or whose postnatal experience was disrupted were given OT later in life, they 
displayed increased social behavior (e.g., increased parental behaviors). While the animal 
research has provided the scientific community with strong evidence of the role of OT in 
behavior, the effects on human social behavior and bonding remain mostly unanswered (Lee 
et al., 2009). 
OT and Social Behavior in Humans 
Increasingly, researchers are beginning to clarify how the animal OT research 
translates to human social behavior. OT is related to reducing depressive (Gordon, et al., 
2008) and anxious (Heinrichs, Baumgartner, Kirschbaum, & Ehlert, 2003) symptoms in 
humans. In fact, OT has demonstrated a robust and consistent relationship with stress and 
anxiety (Lee et al., 2009). OT’s mediating effects of stress is supported by evidence that OT 
is released in the central nervous system (CNS) and peripheral system when humans are 
stressed (Neumann, Kromer, Toschi, & Ebner, 2000). Additionally, lactation in women is 
associated with an increase in OT and decrease in the stress hormones adrenocorticotropin 
(ACTH) and cortisol (Heinrichs, von Dawans, & Domes, 2009). OT has also appears to 
augment the stress-reducing effects of social support (Heinrichs et al., 2003). Heinrichs et al. 
(2003) found that individuals administered intranasal OT and given social support during a 
stress paradigm (giving an impromptu job interview) showed the greatest reduction in stress 
hormone levels compared to those given an intranasal placebo and without social support, as 
well as those given the placebo and with social support present during the stress paradigm. 
These results indicate OT is related not only to anxiety-reduction, but also with increasing 
the anxiolytic effects of social relationships.  
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Aside from the antidepressant and antianxiety effects in healthy controls, underlying 
social cognitive processes are related to OT. A recent review by MacDonald and MacDonald 
(2010) summarizes the evidence that OT improves social cognition in healthy controls. 
Specifically, increased levels of OT are associated with increased trust (Kosfeld et al., 2005), 
correct emotion identification (Domes, et al., 2010) and improved mentalizing (Domes, 
Heinrichs, Michel, Berger, & Herpertz, 2007) in healthy control samples (Lee et al. 2009).  
It should be noted the relationship between OT and emotion identification is 
somewhat complex. Some have found OT is related to improved emotion recognition for all 
emotions in healthy control samples (Domes, Heinrichs, Glascher, et al., 2007), while others 
have found OT is related to improved emotion recognition for specific emotions (Di 
Simplicio, Massey-Chase, Cowen, & Harmer, 2009; Guastella, Carson, Dadds, Mitchell, & 
Cox, 2009). While Di Simplicio et al. (2009) did not find OT improved overall emotion 
accuracy, they did find OT was related to an emotion response bias. Specifically, the OT 
group was significantly less likely to rate neutral faces with a negative emotion (i.e., neutral 
faces were less likely categorized as sad or disgusting), and opted to rate them with a positive 
emotion (e.g., happy). Guastella et al. (2009) found intranasal OT increased recognition of 
angry faces, as well as increased gaze at the angry facial stimuli. Fischer-Shofty, Shamay-
Tsoory, Harari, & Levkovitz (2010) similarly found OT improved identification of only one 
emotion, namely fear. Improvements in fear recognition as a function of OT have supporting 
neurological correlates (Kirsch et al., 2005). Kirsh et al. (2005) found reduced amygdalar 
response in participants given intranasal OT when they were shown fearful faces.  It appears 
OT may have a particular role in regulating fear recognition and response. This is interesting 
given accurate fear recognition has been linked to better social functioning. Marsh, Kozak, & 
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Ambady (2007), for example, found fear recognition was the best predictor of social 
behavior in a healthy control sample. Therefore, it is necessary to evaluate OT’s impact on 
specific emotions, such as fear and anger, as opposed to evaluating emotional accuracy in 
general.  
In addition to emotion recognition, OT has been related to ToM in healthy controls. 
Domes, Heinrichs, Michel, et al. (2007) found that OT was related to increased performance 
on the Eyes Test. Specifically, performance improved on the more difficult Eyes Test items 
(determined by median of item difficulty from a pilot study). One mechanism that may 
mediate the positive effects of OT on mentalizing is increased attention to critical facial 
features, such as the eye region. Indeed, Guastella, Mitchell, and Dadds (2008) found a single 
dose of OT was related to increased gaze to the eye region of human faces in a healthy 
control sample. This is consistent with the attention training research in schizophrenia, where 
emotion perception has shown improvements following instruction to attend to the eye 
regions of faces (Combs et al., 2010).  
The effects of OT extend to social perception, specifically trust in others. Increased 
trust has been repeatedly observed in healthy controls administered intranasal OT (Kosfeld et 
al., 2005).  Kosfeld et al. (2005) found participants administered a single dose of intranasal 
OT gave more money to another participant during a trust paradigm. Interestingly, when a 
risk paradigm was implemented (same as the trust paradigm but without the social 
component), there were no differences between the OT and placebo group in the amount of 
money transferred. Therefore, OT may not be related to reciprocity in general, but more 
specifically with increased trust. Perhaps the trust is facilitated by improved ToM and 
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emotion perception, such that one is more apt to trust another if they can more accurately 
perceive their cognitive and affective states.  
There has also been research looking at the effects of intranasal OT on empathy in 
humans, which is unsurprising given the association between OT and increased feelings of 
bonding (Carter et al., 1992). Hurlemann et al. (2010) found intranasal OT improved 
emotional, but not cognitive empathy. In Hurlemann et al.’s study, OT increased emotional 
empathy in men to levels comparable to the women in their sample, which were significantly 
different before the intranasal OT dose. Hurlemann et al. hypothesize that cognitive and 
emotional empathy may have different neurological underpinnings, where emotional 
empathy is related to amygdalar functioning. Their results are somewhat inconsistent with 
research showing OT improves ToM, since cognitive empathy is closely related to ToM; 
however, Hurlemann et al.’s assessment of cognitive empathy involved social scenes where 
participants were asked to guess how the people were feeling in the scenes (i.e., participants 
could not directly see the faces of the individuals in the scenes). This is in contrast to the 
Eyes Test where the stimuli are the eye regions of faces and participants stare directly at the 
stimuli. Perhaps participants in Hurlemann et al.’s study did not improve on the cognitive 
empathy measure because they could directly see the faces and thus were not able to discern 
the mental states. Clearly more research is needed to elucidate OT’s role in empathic 
processes, but this preliminary research suggests it may indeed have an impact on it.  
Given OT’s relationship with social cognition, it would reason that OT is associated 
with social functioning in humans. One study found that intranasal OT improved positive 
social behavior (e.g., eye contact, validation, non verbal positive behavior) in married 
couples (Ditzen et al., 2009). OT may also strengthen the processes underlying social 
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behavior, namely social cognition, and thereby improve social functioning. Of course, the 
directionality and relationship between OT and social behavior is unknown; for instance, it is 
possible that the relationship is bi-directional in that social withdrawal could lead to 
decreased social relationships and a reduction in OT. Lower OT levels, in turn, may have a 
deleterious impact on social cognitive processes, such as emotion perception, and positive 
social behavior (i.e., social skills). Such a transactional relationship is supported by OT’s 
association with perceived reward in social interactions (Bell, Nicholson, Mulder, Luty, & 
Joyce, 2006). That is, lower levels of OT are related to not finding social interactions 
rewarding. Lack of social reinforcement may prevent individuals from practicing social skills 
and lead to further impairments in social functioning.  
OT in Schizophrenia and Other Clinical Populations 
The role of oxytocin in psychiatric disorders has been evaluated in light of the 
evidence of its anxiolytic, antidepressant (Bell et al., 2006; Ozsoy, Esel, & Kula, 2009) and 
antipsychotic effects (Caldwell, Stephens, & Young, 2009; Feifel, Shilling, & Belcher, 
2012), as well as the aforementioned impact OT appears to have on underlying social 
cognitive processes. In fact, there has been a recent surge in reviews of OT’s role in 
psychiatric disorders (Bartz, Zaki, Bolger & Ochsner, 2011, Lee et al., 2009; Macdonald & 
Macdonald, 2010; Marazziti & Catena Dell'osso, 2008). The reviews highlight the 
predominance of research investigating OT in animal models and healthy controls and 
indicate there is a need for more research in psychiatric populations, particularly disorders 
where social behavior is severely compromised such as schizophrenia. Macdonald and 
Macdonald (2010) discuss the therapeutic implications for clinical populations and the 
preliminary evidence of OT’s therapeutic effects in disorders such as schizophrenia and 
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autism. Macdonald and Macdonald (2010) argue OT’s relevance to a variety of psychiatric 
disorders does not diminish its utility; rather social relations are frequently affected in 
psychological disorders, so it reasons OT can be applied to multiple disorders.  
Abnormal OT levels have been observed in schizophrenia as compared to healthy 
controls (Beckmann, Lang, & Gattaz, 1985; Goldman, Marlow-O'Connor, Torres, & Carter, 
2008). OT has also demonstrated antipsychotic properties (Bakharev, Tikhomirov, & 
Lozhkina, 1986; Bujanow, 1974; Caldwell et al., 2009; Feifel et al., 2010; Pedersen et al., 
2011) and shown to restore Prepulse Inhibition (PPI; Feifel et al., 2012; Feifel & Rezza, 
1999). PPI is a measure of sensorimotor gating, where a reduced startle response to a 
stimulus is observed when it is preceded by a weaker stimulus. Individuals with 
schizophrenia display a decreased PPI response and antipsychotics reverse the disrupted PPI 
seen in schizophrenia (Feifel et al., 2012; Feifel & Rezza, 1999). Interestingly, Feifel et al. 
(2012) found that OT could similarly restore PPI in rat models of psychosis, which is 
consistent with the effects of antipsychotics.  
Earlier studies (e.g., Bakharev et al., 1986) found some of the first evidence OT could 
reduce psychotic symptoms, as well as other symptoms such as anxiety in individuals with 
schizophrenia. In one treatment trial, Bakharev et al. (1986) found intranasal OT was related 
to decreased negative symptoms (e.g., apathy). Two recent trials have similarly found OT 
reduces symptoms in schizophrenia (Feifel et al., 2010; Pedersen et al., 2011).  Feifel et al. 
(2010) conducted a three-week, cross-over trial; they administered 20 international units 
(IUs) of OT for the first week and 40 IUs of OT for the last two-weeks of the trial. They 
found OT was related to an overall reduction of psychotic symptoms.  Interestingly, the 
treatment effects for positive and negative symptoms were most prominent at the three-week 
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study visits as compared to the two-week visits. In Pedersen et al.’s (2011) randomized 
control trial, they found significant reductions in a variety of symptoms (positive, general, 
anxiety) and a trend reduction in negative symptoms after two-weeks of 24 IUs of intranasal 
OT. These studies suggest OT has therapeutic implications of for the treatment of 
schizophrenia-related symptoms.  
However, the majority of the OT research has focused on OT’s amelioration of the 
symptoms of schizophrenia.  Less attention has focused on targeting social cognitive 
processes, which is surprising in light of the animal and healthy control research linking OT 
with social cognition (Macdonald & Macdonald, 2010). In the OT and social cognitive 
research that does exist, autism has been one of the most studied disorders. In fact 
researchers have begun to explore abnormalities in genes responsible for OT expression in 
autism (Lee et al., 2009). Lower levels of OT plasma have been found in autism, and there is 
preliminary evidence intranasal OT can improve affect recognition in autism (Yamusue, 
2009). Guastella et al. (2010) found a single dose of intranasal OT in autism spectrum 
disorders improved ToM as measured by performance on the Eyes Test. OT has also shown 
to reduce the repetitive, self-stimulating behaviors often observed in autism (Hollander et al., 
2003). Overall, the autism literature is promising and suggests that OT can be applied to 
other populations where social cognition is impaired, such as schizophrenia.   
Autism and schizophrenia are often compared because of their similar social 
cognitive deficits (Couture et al., 2010), and psychological treatments targeting social 
cognition in schizophrenia, such as social cognition and interaction training (SCIT; Roberts 
& Penn, 2009; Roberts, Penn, Labate, Margolis, & Sterne, 2010), have previously been 
adapted to autism (Turner-Brown et al., 2008). Thus, it is theoretically reasonable to apply 
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OT to social cognition in schizophrenia. Researchers have only begun to postulate about the 
potential benefits of OT in remediating social cognitive deficits in schizophrenia. Rosenfeld, 
Lieberman, & Jarskog’s (2010) recent review paper discusses OT and social cognitive 
research, as well as hypothesize that OT can make a significant contribution to our 
understanding of social cognition in schizophrenia. There have even been a few empirical 
studies looking at the relationship between OT and social cognition in schizophrenia. In one 
study, low levels of OT in schizophrenia were associated with decreased emotion perception 
accuracy (Goldman, Marlow-O'Connor, Torres, & Carter, 2008). Keri et al. (2009) found 
significantly lower OT levels in those with schizophrenia compared to healthy controls after 
a trust interaction (writing a secret on a piece of paper and presenting it to the tester). Keri et 
al. additionally found that low levels of OT were related to negative symptoms and were not 
related to cognitive functioning or medication.  
There have only been three trials evaluating the effects of exogenous OT on social 
cognition in schizophrenia; two of these have focused on emotion recognition (Averbeck et 
al., 2012; Goldman et al., 2011) and the other (Pedersen et al., 2011) examined social 
perception and theory of mind. Averbeck et al. (2012) used a placebo-controlled, cross-over 
trial to assess the effects of OT on emotion recognition in schizophrenia; specifically, half of 
the participants first received either OT or PL and then came back for testing a week later 
and received their second dose of either OT or PL (since they used a cross-over design, 
participants only received one 24 IU OT dose). Averbeck et al. found overall improvement in 
emotion recognition and a trend towards significantly improved fear recognition using a 
subset of Ekman’s faces. Goldman et al. (2011) examined multiple OT doses (2 total doses) 
in a subgroup of individuals with schizophrenia (e.g., polydipsic).  Participants received 2 
!  
 
 %&!
!
different doses of OT and a placebo three days apart (10 and 20 IUs of OT) and completed 
the Ekman facial recognition task at each time point. In addition to identifying the emotions 
displayed, they rated the intensity of the emotions (absent, present, intense). Goldman et al. 
found that the 20 IU dose lowered intensity ratings in the polydispsic group.  In addition, 
they found that the higher OT dose (20 IU), but not the lower dose (10 IU), increased 
emotion recognition accuracy. Specifically, the improvements in their study were found for 
fearful faces in the polydipsic schizophrenia sample. In fact, they found that 10 IUs actually 
decreased affect recognition in all participants with schizophrenia.   
 In Pedersen et al.’s (2011) randomized-control trial, participants received daily OT 
for two weeks and completed a social cognitive battery at baseline and two weeks. Results 
showed significant improvements on second order false belief ToM (i.e., the ability to 
discern what an individual is falsely thinking about another’s thoughts or intentions) as 
measured by the Brune Task and a trend towards rating untrustworthy faces (i.e., faces rated 
as untrustworthy by a normative sample) as trustworthier in the OT group. Notably, Pedersen 
et al. examined multiple rather than single OT doses; whereas the previous two studies 
examining OT and social cognition evaluated either one (Averbeck et al., 2012) or two 
(Goldman et al., 2011) doses. These results are promising and underscore the need to 
investigate OT in a longer clinical trial assessing a broader range of social cognitive 
measures.  
The Current Study 
Given the evidence that antipsychotics do not improve social cognition or functioning 
(Bellack et al., 2004; Harvey et al., 2006; Penn et al., 2009), there is a need to investigate the 
effects of OT on social cognition and social functioning in schizophrenia. The current study 
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evaluated the effects of OT on facial emotion recognition, theory of mind (ToM), empathy, 
social perception and attribution style. The aims and hypotheses will follow accordingly. 
Additionally, the effects of OT on social and community functioning were explored in light 
of the relationship between social cognition and these life domains (Couture et al., 2006; 
Smith et al., 2012).  
Aims & Hypotheses 
Aim 1: Evaluate the effects of OT on facial emotion recognition, specifically fear 
and anger.  
The first aim was to evaluate the effects of OT on facial emotion recognition. 
Averbeck et al.’s (2012) and Goldman et al.’s (2011) findings suggest OT has a role in 
emotion recognition in schizophrenia. Specifically, OT may improve recognition of the 
emotions of fear and anger in schizophrenia given the evidence that OT improves recognition 
of these emotions in healthy controls (Fischer-Shofty, Shamay-Tsoory, Harari, & Levkovitz, 
2010; Guastella et al., 2009) and preliminary evidence that it improves fear recognition in 
schizophrenia (Averbeck et al., 2012; Goldman et al., 2011). This aim is further supported by 
Morris et al.’s (2009) argument that OT may reduce amygdalar activation to fearful faces in 
schizophrenia and thereby reduce distress that comes from negative emotional stimuli. 
Therefore, it was hypothesized that OT would improve recognition of fear and anger in 
schizophrenia using a well-validated, behavioral facial emotion recognition task, The ER-40 
(Carter et al., 2009).  
Aim 2: Evaluate the effects of OT on Theory of Mind (ToM).  
The second aim was to examine the degree to which OT impacts ToM. As was 
discussed earlier, ToM is best conceptualized as a multidimensional construct (Sabbagh, 
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2004; Shamay-Tsoory, Shur, Barcai-Goodman, et al., 2007). Therefore, the current study 
explored affective and cognitive ToM. OT appears to have beneficial effects on ToM based 
on the research with healthy controls (Domes et al., 2007) and individuals with autism 
(Guastella et al., 2010).  Pedersen et al.’s (2011) two-week trial provides preliminary 
evidence OT can improve cognitive ToM. (Note that ten of the participants in the current 
study are from the Pedersen et al., 2011 trial.) Based on the current body of evidence, it was 
hypothesized that OT would improve cognitive ToM using a social-reasoning cognitive ToM 
task, namely the Brune Task. It was also hypothesized OT would improve affective ToM as 
measured by a behavioral affective ToM task, the Eyes Test.   
Aim 3: Evaluate effects of OT on empathy.  
The next aim was to evaluate the relationship between OT and empathy in 
schizophrenia. OT is associated with feelings of closeness (Carter et al., 1992) and evidence 
with healthy controls suggests OT is associated with increased empathy (Hurlemann et al., 
2010). Since empathy is closely related to affective ToM (Derntl, et al., 2009) and emotion 
perception (Feschbach, 1987; Green et al., 2008), it stands to reason that OT could lead to 
increased empathic processing in schizophrenia. The current study used a well-established 
self-report empathy measure, the IRI (Davis, 1983), to assess the effects of OT on cognitive 
and affective empathy. It was hypothesized that OT would improve self-reported empathy in 
schizophrenia.  
Empathy was also assessed with a newly developed performance-based measure (i.e., 
a role play test). A performance-based empathy measure may contribute to our understanding 
of empathy in schizophrenia given the empathic literature is predominated by self-report 
measures. Since the performance-based measure is newly developed and not yet validated, 
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performance on the empathy role-play was considered exploratory; however the preliminary 
psychometric properties of the role-play empathy measure were also assessed. 
Aim 4: Evaluate effects of OT on social judgments.  
There is initial support that intranasal OT can increase trustworthiness in individuals 
with schizophrenia (Pedersen et al., 2011). Additionally, Keri et al. (2009) found lower OT 
plasma levels in individuals with schizophrenia were related to decreased trust during a 
trustworthiness paradigm. Thus, aim four was to explore how OT impacts social judgment on 
a behavioral measure of trustworthiness, namely the Trustworthiness Task (Adolphs et al., 
1998).  It was hypothesized that the OT group would have improved social judgment, such 
that ratings on the trustworthiness task would be similar to ratings observed in healthy 
controls. Specifically, it was hypothesized that OT would be related to greater ratings of 
trustworthiness.  
Exploratory Aims  
Exploratory Aim 1: Evaluate effect of OT on attribution style. 
Since no current research has directly explored how OT affects attribution style in 
schizophrenia (nor in non-clinical samples in general), the first exploratory aim was to 
examine the effects of OT on attribution style in schizophrenia using a behavioral task, 
namely the AIHQ. This is a worthwhile endeavor since there is some evidence that 
attribution style is related to functional outcome (Couture et al., 2006). It is possible OT can 
impact attribution biases, such as the personalizing bias, through OTs effects on paranoia 
(Pedersen et al., 2011). Additionally, OT has shown to reduce reactivity to threat cues 
(Kirsch et al., 2005), which could manifest in reduced external attributions for ambiguous or 
negative events.  
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Exploratory Aim 2: Evaluate effects of OT on social and community functioning. 
An additional aim was to examine how OT impacts social functioning using a 
functional capacity (i.e. role play) measure and community functioning using a self and 
informant report measure. Since OT has been related to improved social skills in healthy 
controls (Ditzen et al., 2009), OT may have a similar observable effect on functional capacity 
in schizophrenia. The relationship between social cognition and social functioning also 
suggests OT could have an effect on functional capacity. However, the research in this area is 
lacking in clinical populations, and so the effects of OT on functional capacity were 
considered exploratory.  
In light of research showing improved social functioning is related to better 
community functioning (Couture et al., 2006; Evert et al., 2003), the impact of OT on 
community functioning over the course of the present study’s treatment trial was additionally 
explored.  Due to potential lack of insight in functioning deficits, both informant and self-
reports were administered to examine community functioning.  
Exploratory Aim 3: Moderator and Mediators of OT effects on social cognition. 
Due to a potentially limited sample size, evaluating mediators and moderators was 
considered exploratory. Hoyle and Kenny (1999) have found that simple mediation models 
are indeed possible with small sample sizes. To better characterize possible treatment effects, 
it was considered critical to evaluate whether there were any variables that may potentially 
mediate, as well as moderate the effects of OT on multiple domains of social cognition. 
Specific mediators that were proposed to explore included anxiety and neurocognition. Since 
OT has known anxiolytic effects (Lee et al., 2009), treatment effects on anxiety could 
influence performance on social cognitive measures, such that improved social cognitive 
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performance could be a function of decreased anxiety. Additionally, given the research 
demonstrating OT is tentatively related to improved cognitive abilities (Macdonald & 
Macdonald, 2010), neurocognition was also tested as a mediator. Lastly, gender was explored 
as a moderator; animal studies have shown that OT has a greater effect on social behavior in 
male than female voles (Carter et al., 2009) and there is an array of studies showing 
differential effects of OT on social cognition in men and women (e.g. Hurlemann et al., 
2010; Rubin et al., 2011). Thus, the current study had proposed to evaluate the possible 
interaction between gender and OT on social cognition.  
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        CHAPTER II 
 Methods 
Participants  
Twenty participants were recruited as part of the Oxytocin Treatment of Social 
Deficits and Psychotic Symptoms in Schizophrenia study conducted at the Clinical and 
Translational Research Center (CTRC) at the University of North Carolina Hospitals and the 
North Carolina Psychiatric Research Center (NCPRC). (Note, five of the participants in the 
current sample were part of a 12-week OT treatment trial and the other 15 participants were 
part of the 6-week OT trial; differences in inclusion/exclusion criteria are discussed below.) 
Participants were recruited from UNC’s Department of Psychiatry Schizophrenia Treatment 
and Evaluation Program (STEP) outpatient clinics, the UNC Hospitals Psychotic Disorders 
inpatient unit, the inpatient unit at Dorothea Dix Hospital, other studies conducted at UNC 
Hospitals, as well as flyers in the community and advertisements in the National Alliance of 
Mental Illness (NAMI) newsletter.  
The inclusion criteria for the 6 and 12-week OT trials were generally consistent. For 
both trials, inclusion criteria included the following: stability of symptom severity; on the 
same medication(s) and dose(s) for at least one-month prior to study participation; and, low 
to moderate depressive symptoms.  The age criterion for the 6-week trial was 18 to 55 years 
of age to participate; it was expanded in the 12-week trial to 65 years of age.  There were 
three main differences in inclusion/exclusion criteria for the two trials involving diagnosis, 
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symptom severity, and baseline social cognition (Table 1).  Diagnosis was based on 
extensive chart review and consultation with the attending psychiatrist. The Structured 
Clinical Interview for DSM-IV Axis I Disorders (SCID-I; First et al., 2002), Mood Disorders 
and Psychotic Disorders modules was administered by trained research clinicians or 
advanced graduate students for participants who not been followed by UNC’s Department of 
Psychiatry or participants whose diagnosis was unclear (e.g., schizophrenia versus 
schizoaffective disorder).  
Exclusion criteria for both trials included low literacy as indicated by an inability to 
read and understand the consent form and performance on the Wide Range Achievement 
Test (WRAT; only administered in the 12-week OT trial), dependence on substances other 
than tobacco or caffeine; positive urine drug screen for illegal substances or drugs that have 
not been prescribed; debilitating medical conditions; major surgery or trauma in the past 
year; pregnancy or breast-feeding; having given birth in the past 6 months or breast-feeding 
in the past 3 months; abnormalities found during medical evaluation during study 
participation; and, an inability to learn self-administration of intranasal treatments.  
Procedures 
The current study used a randomized, double-blind, placebo-controlled design. Half 
of the participants (n=10) received an oxytocin nasal spray and half (n=10) received a normal 
saline placebo nasal spray. Potential participants were contacted by study staff and completed 
a telephone screen (described in more detail below) to determine study eligibility.  
Participants completed a screening visit to further determine eligibility based on the 
aforementioned inclusion and exclusion criteria. Before the screening visit began, 
participants read the informed consent document and were asked to answer questions about 
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the consent to ensure they understood the document. In order to participate in the study, 
participants must have been able to read and understand the informed consent document.  
Baseline measures of social cognition, social functioning, community functioning, 
neurocognition and psychiatric symptoms were then obtained for eligible participants 
(measures are described below). The schedule of study visits was different for the 6 and 12-
week trials. Both trials collected social cognition, social functioning, and psychiatric 
symptoms at baseline and 6 weeks. While both studies assessed neurocognition and 
community functioning at baseline, these areas were only assessed at 6 weeks for the 6-week 
OT participants (and not the 12-week participants). The participants from the 6-week trial 
had additional study visits at the 2 and 4-weeks, while the 12-week participants did not 
complete social cognitive measures at 2 and 4 weeks. The social cognitive, symptom, social 
and community functioning measures and a flow sheet of the study visit procedures for both 
trials can be found in the Appendix. 
During the baseline visit, participants identified two people that knew them well (e.g., 
family member, friend, mental health professional) to complete the informant version of the 
community functioning assessment, the Specific Levels of Functioning (SLOF) scale 
(described below).  Informants who have frequent contact with the study participant (e.g., 
speak on the phone daily, see each other at least twice a week) were asked to complete the 
SLOF over the phone with a research clinician or psychology graduate student once at 
baseline and again at 6-weeks for participants in the 6-week trial only.  
 Participants received a 60-milliliter (ml) spray vial containing 30 ml of test solution, 
which was administered twice daily for six weeks (approximately 24 International Units). 
They were given their first dose immediately after the baseline measures were administered. 
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Participants were then given new vials at each study visit. Participants in the 12-week trial 
were given two 30 ml vials at their 2-week visit to ensure they had an adequate amount of 
spray to last until their 6 week visit. The vials were weighed before the participants took the 
vials home and then again when they returned so as to track compliance with the study 
treatment (see flow sheet in Appendix for schedule of compliance tracking).   
Participants were called daily for two to seven days after their baseline visit by 
research staff. These reminder calls were intended to remind participants to take the spray, 
assess that they were administering it correctly and assess for adverse effects.  Participants 
who had more difficulty remembering to take the nasal-spray or trouble with the 
administration instructions were called more frequently during the first week. Participants 
were called weekly for the remainder of the study once they demonstrated that they 
remembered to take the spray and were familiar with the administration.   
The study visits lasted about two hours for the social cognition and social functioning 
measures. Trained psychology graduate students, research assistants or advanced 
undergraduate students administered the social cognitive and social functioning measures. 
Trained psychology graduate students or clinicians administered the symptom measures. 
Study staff administering the assessments were blind to treatment group. Trained 
undergraduate research assistants, also blind to treatment group, rated the role-plays and the 
attributional style measure (i.e., AIHQ; as described below). 
Measures 
Screening measures. 
Telephone Screen. 
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A telephone screen was developed to screen participants for inclusion criteria, such as 
diagnosis and substance use in the last year. The telephone screen includes questions tapping 
into the potential participant’s comfort in social situations (e.g., “How do you react to the 
presence of strangers?”). The potential participant was asked to elaborate on their perceived 
difficulty in social settings.  Based on the telephone screen and consultation with the 
potential participant’s mental health professionals, participants were scheduled for a 
screening visit. 
 Psychotic Symptoms.  
             The Positive and Negative Symptoms Scale (PANSS; White et al., 1997) is a 30-item 
scale on which an interviewer rates the subject for severity of positive and negative psychotic 
symptoms and mood and behavioral symptoms after asking a standard series of questions.  
Items are rated on a scale of 1 (absent) to 7 (severe), and yield three main subscores: positive 
symptoms, negative symptoms, and general psychopathology. The PANSS was administered 
by an experienced psychiatric clinician or trained doctoral graduate students blind to 
treatment group. 
Social cognitive measures. 
Emotion Perception. 
 
The Emotion Recognition-40 (ER-40; Kohler, Turner, Gur, & Gur, 2004) consists of 
a series of 40 faces, shown one at a time on a computer screen. Participants choose the 
correct emotions based on 5 answer choices: happy, sad, anger, fear and no emotion. 
Participants indicate the word that best describes the emotion each faces expresses. A 
practice item is administered to ensure the participant understands the task and can see the 
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stimuli. The stimuli are presented in a randomized order each time they are administered. A 
scoring program automatically records accuracy and median response time.  
The ER-40 faces were derived from the University of Pennsylvania Emotion 
Recognition Task, 96 faces version, and are balanced for equality and intensity of emotion, 
age, gender and ethnicity. As mentioned earlier, the ER-40 has showed strong psychometric 
properties, such as high-levels of test-retest reliability in schizophrenia samples and does not 
show ceiling effects (Carter et al., 2009). A sample ER-40 stimulus can be found in the 
Appendix.  
 Theory of Mind. 
 In the Theory of Mind Picture Stories Task (Brune, 2003), participants are shown 
a series of six sets of four cartoon pictures that illustrate interactions between two or more 
individuals. The cartoon cards were displayed to the participant in a predetermined 
scrambled order (i.e., they are displayed to each participant in the same scrambled order). 
Participants are asked to rearrange the pictures in an order that conveys a logical story. 
Participants are given two practice items and provided with feedback to ensure they 
understand the task.  
 The period of time the subject takes to complete the task and the accuracy of the 
sequencing is recorded. After the participant arranges the cards, the examiner ensures they 
are in the correct sequence. If they are not in the correct order, the examiner silently arranges 
them so they are in the logical sequence and never reveals to the participant why they are 
rearranging the cards; providing feedback as to whether they sequenced the cards correctly 
may influence the participant’s responses to the follow-up questions and increases the 
likelihood of practice effects. The participant is then asked a series of questions about the 
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cards, which are meant to tap into different aspects of Theory of Mind, such as first order 
ToM (e.g., what the character thinking), second order ToM (e.g., what a character is thinking 
about another character’s intentions), second order false belief (e.g., what a character is 
falsely thinking about another character’s intentions), third order false belief (e.g., what a 
character is thinking that another character is falsely thinking about their intentions), 
deception (identifying a character’s deceptive intentions) and reciprocity (identifying that a 
character is expecting another character share or reciprocate). The participant’s 
interpretations of the characters’ beliefs are scored as correct or incorrect (zero or one), with 
higher scores indicating better ToM.  The scoring of the sequencing of the cards is based on 
Langdon et al.’s (1997) approach to scoring card sequencing tasks. Two points are given for 
correctly ordering the first and last card and one point is awarded for each of the two middle 
cards placed correctly. Thus, participants can receive a total of 36 points for correctly 
ordering the cards and 23 points for the questions. There is an alternate version of the Brune 
Task (i.e., six different stories tapping into the same components of ToM). Two participants 
in the 12-week trial were administered the alternate version at their 6-week visit; all other 
participants were administered the same original Brune version.  A sample story sequence is 
found in the Appendix.  
The Eyes Test (Baron-Cohen, Wheelwright, Hill, Raste, & Plumb, 2001) consists of 
36 photographs where participants are asked to guess the mental state (i.e., what the person is 
thinking or feeling) from among four choice words. Participants are given a practice item to 
ensure that they understand the task. Each eye region is displayed on a computer screen with 
the four choice mental states shown in the four corners of the computer screen (one target 
word and three foil words). A sample stimulus from the Eyes Test is in the Appendix. There 
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is no time constraint in choosing the mental state. Performance is measured by the number of 
faces correctly discriminated. Although the Eyes Test was originally designed to assess ToM 
in Autism (e.g., Baron-Cohen et al., 2001), it has been frequently applied to schizophrenia 
samples (e.g., Couture et al., 2008; Irani et al., 2006; Kelemen et al., 2005). A glossary of the 
mental states was made available, if the participants were unsure of the meaning of a word. 
Empathy. 
The Interpersonal Reactivity Index!.IRI; Davis, 1983) is a self-report measure of 
cognitive and affective empathy. The IRI consists of 28 items where participants rate how 
well each item describes them using a five-point scale.  Participants in the current study were 
asked to rate the items using the last month as a time-frame (i.e., more recent behavior, etc.). 
The 28 items yield four subscales: perspective taking (PT), empathic concern (EC), fantasy 
(F), and personal distress (PD). The PT subscale measures the tendency to take another’s 
point of view (e.g., “I sometimes try to understand my friends better by imagining how things 
look from their perspective”). The EC subscale measures feelings of sympathy and concern 
for others (e.g., “I often have tender, concerned feelings for people less fortunate than me”). 
The F subscale measures the ability to imagine oneself in the role of a fictitious character in 
books (e.g., “When I am reading an interesting story or novel, I imagine how I would feel if 
the events in the story were happening to me”). The PD subscale measures personal feelings 
of anxiety and unease in interpersonal settings (e.g., “Being in a tense emotional situation 
scares me”). The IRI has shown high levels of construct validity (Lawrence, Shaw, Baker, 
Baron-Cohen, & David, 2004) and internal consistency (Davis, 1983). Additionally, the IRI 
has been used to assess self-reported empathy in individuals with schizophrenia (e.g., Derntl 
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et al., 2009; Montag et al., 2007).  The IRI has shown to be sensitive to treatment effects in 
non-clinical samples (e.g. Sands, Stanley and Charon, 2008)  
The internal consistency of the IRI in the current study was explored. The majority of 
the subscales demonstrated adequate reliability; however the Perspective-Taking at baseline 
and the Distress subscale at baseline and 6-weeks showed poor internal consistency: 
[(Baseline Cronbach’s alphas: Fantasy=.74; Emotional Concern=.80; Perspective 
Taking=.31; Distress=.15) and (6-week Cronbach’s alphas: Fantasy=.75; Emotional 
Concern=.66; Perspective Taking=.60; Distress=.35)].  Thus, findings regarding these two 
subscales should be interpreted carefully. 
In addition to a self-report measure, a newly developed empathy role-play measure 
and rating scheme was used to assess empathic abilities. The role-play scenario is meant to 
elicit an empathic response from the participant. The participant is told that their friend is 
unhappy and their goal is to find out the reason for their sadness and alleviate their friend’s 
distress.  During the role-play, the confederate (played by the research assistant) reveals that 
they are sad because they were not hired for a job that they thought they were going to 
receive. The scenarios are slightly different for the 6-week visit to reduce potential practice 
effects (e.g., in the 6-week visit role-play, the confederate is sad because their friend did not 
come to visit them).  
The role-play lasts 90-seconds and is videotaped. The research assistant informs the 
participant about the purpose and structure of the role-play before the 90-seconds begins. The 
research assistant then asks the participant to repeat back the purpose of the role-play to 
ensure that the participant understands the task before proceeding. The empathy role-play 
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was performed immediately after an initial social skills role-play (described later under the 
social functioning measures section).   
Performance on the empathy role-play was rated with a newly developed rating 
scheme informed by the empathy literature. (In addition to empathic abilities, social skills 
were also assessed in the empathy role-play; this will be discussed later in the social 
functioning measure section.) Specifically, there is evidence that empathy is most accurately 
conceptualized as a multidimensional construct, consisting of both affective and cognitive 
components (Decety & Jackson, 2004) and that empathy is facilitated by mimicking other’s 
behavior and emotional states (Decety & Jackson, 2004; Iacoboni, 2009). Although there are 
current observer-rated empathy rating schemes, such as those used to evaluate physician 
empathy with patients (e.g., Evans, Stanley, & Burrows, 1993), there are no current rating 
systems that similarly deconstruct empathy into its constituent components  (i.e., current 
rating schemes are approached from a one-dimensional perspective).   
The rating scheme for the empathy role-play consisted of five items assessing the 
following components of empathy: cognitive empathy (e.g., how well does the participant 
communicate to the confederate that they understand how they are feeling, and the degree to 
which they are able to affectively perspective-take), emotional empathy (e.g., displaying 
sympathy and concern), ideomotoric empathy (e.g., the level of behavioral mimicking, 
matching body language), helpfulness (e.g., reassurance and problem-solving) and lastly, a 
summary empathy item (e.g., how well did the participant display and communicate empathy 
overall). The items are rated on a one to five rating scale, with higher scores indicating more 
empathy. Two independent and blind raters were trained to reliability on the empathy rating 
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measure. One of the raters did not complete all of the tapes in the current study, thus a 
majority of empathy role-plays (n=16) were rated by one trained rater.  
 Social perception. 
 The Trustworthiness Task (Adolphs, Tranel, & Damasio, 1998) is comprised of 42 
black and white photographs of the faces of unfamiliar people. Participants are shown each 
picture individually (on a computer monitor) and asked to rate how much they would trust 
that person (e.g., with their money) on a seven-point scale, ranging from -3 (very 
untrustworthy) to +3 (very trustworthy).  They are provided with a photograph of 0 or an 
average face (i.e., someone they would neither trust nor distrust) to refer to throughout the 
task (based on Adolphs et al.’s, 1998 norms). The total score is the sum of the 
trustworthiness ratings. An additional method of scoring used previously (e.g., Adolphs et al., 
1998; Couture et al., 2008) is to create two scales based on the top third of the most 
trustworthy faces (score of +1 or greater) and the bottom third of untrustworthy faces (score 
of -1 or below) based on a Adolph et al.’s (2008) normative sample.  
 Attribution style.  
 The Ambiguous Intentions Hostility Questionnaire-Abbreviated Version (AIHQ, 
Combs et al., 2007) evaluates attribution style. The AIHQ-abbreviated version is comprised 
of five short vignettes that reflect negative events that are ambiguous in intention.  
Participants are read each vignette, and asked to imagine the scenario happening to them 
(e.g., “You walk past a bunch of teenagers at a mall and you hear them start to laugh”), and 
to think of the reason why the other person (or persons) acted that way towards them.  
  Two independent and reliable raters subsequently rated the responses for hostility 
(“hostility bias”) using a five point Likert scale (higher scores indicating more hostility).  The 
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participant then uses Likert scales to rate whether the other person (or persons) performed the 
action on purpose, how angry it would make them feel, and how much they would blame the 
other person (or persons); these responses are averaged to yield a “blame bias.” Finally, the 
participant is asked to write down how they would respond to the situation, which was later 
rated by the same two independent and reliable raters to compute an “aggression index.” 
Again, the raters use a five point Likert scale, with higher scores indicating more aggression.  
 The AIHQ has demonstrated high levels of reliability and validity in schizophrenia 
samples (Combs, Penn, Wicher, & Waldheter, 2007) and been used to assess psychosocial 
treatment effects for schizophrenia (e.g., Combs, Adams, et al., 2007). In the current study, 
two independent raters, both blind to condition, were trained to become reliable on the 
AIHQ.  
 Social Functioning Measures. 
To evaluate social functioning, a role-play measure was administered at the baseline 
and 6-week visits. Role-plays are routinely used in schizophrenia research to assess social 
skills and are related to real-world functioning (e.g., Bellack et al., 1990). The current study 
used two role-play scenarios at each time point (baseline and 6-weeks). One of the role-play 
scenarios, the empathy role-play, was previously discussed. In addition to the empathy 
scenario, an initial role-play was conducted where the participant is instructed to have a 
conversation with their new neighbor. Their goal is to get to know their new neighbor 
(played by the study confederate). The scenarios are again slightly different at the 6-week 
visit (e.g., instead of meeting a new neighbor, the participant meets a new friend at a party). 
The confederate for both the empathy and social functioning role-play were trained research 
clinicians, doctoral level graduate students, or advanced undergraduate research assistants.  
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Efforts were made to ensure that the same confederate completed the baseline and week-6 
visit for participants; in the event that the same confederate was not available, one of the 
trained research staff acted as the confederate. The role-play scenarios and confederate 
instructions were standardized to minimize the potential impact of having a different 
confederate complete the second role-play.  
Both the first role-play (e.g., meeting the new neighbor) and the empathy role-play 
were coded with a social skills rating manual. A similar coding scheme has been used 
previously and demonstrated high levels of reliability and validity (e.g., Pinkham & Penn 
2006). The social skill manual measures behaviors such as eye-gaze, anxiety, engagement, 
number of questions asked, fluency of speech (e.g., absence of speech fillers), clarity of 
speech (e.g., clear enunciation), meshing (e.g., the flow of the conversation), content (e.g., 
the appropriateness of the content), appropriate affect, flat affect and overall interpersonal 
skill. One difference between the rating scheme used by Pinkham and Penn (2006) and the 
current rating scheme is that this study used a five point rating scale as opposed to a nine-
point scale so as to further increase inter-rater reliability.  
As has been done in previous studies using a similar social skills rating scheme (e.g., 
Penn, Mueser, Spaulding, Hope, & Reed, 1995; Pinkham, Penn, Perkins, Graham, & Siegel, 
2007), the social skills items were grouped by global skills (i.e., content, overall social skill 
item, social anxiety), specific skills (i.e., questions, fluency, clarity, meshing, involvement) 
and non-verbal social skills (i.e., gaze, facial affect, appropriate affect). Higher ratings on the 
rating scale indicate better social skills. Two independent raters (the same raters who 
completed the empathy ratings) were trained to reasonable levels of reliability on 13 tapes 
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(e.g., ICCs > .60); however, only one rater completed a majority of the role-plays (n=16) in 
the current study.  
Community Functioning. 
Specific Levels of Functioning Scale (SLOF; Schneider & Struening, 1983) is a 
measure of community functioning. The SLOF has an informant and self-report version, both 
of which were included in the present study.  The SLOF measures overall functioning in a 
variety of domains such as interpersonal relationships (e.g., initiates contact with others), 
social acceptability (e.g., destroys property), work skills (e.g., has employable skills) and 
daily living activities (e.g., can handle personal finances) and has shown strong psychometric 
properties in schizophrenia samples (Bowie et al., 2008). Each item is rated on a 5-point 
likert scale with anchors describing the frequency of the behavior and/or the patient’s level of 
independence.  Higher scores indicate more adaptive community functioning. Since the 
interpersonal relationships and social acceptability subscales of the SLOF converge on social 
functioning, these subscales were additionally combined and analyzed to assess the 
relationship between OT and social functioning.  
 Anxiety Symptoms.  
The Liebowitz Social Anxiety Scale (LSAS; Liebowitz, 1987) is a self-rating 
instrument that lists 24 social situations that the participant rates for how much fear/anxiety 
they would experience and how much they would avoid each situation on a scale of zero to 
three. Higher numbers indicate greater levels of anxiety and frequency of avoidance. The 
LSAS has previously shown high levels of reliability and validity (e.g., Baker, Heinrichs, 
Kim, & Hofmann, 2002; Fresco et al., 2001) and has been previously used to assess social 
anxiety in schizophrenia (e.g., Mazeh et al., 2009; Pallanti, Quercioli, & Pazzagli, 2000).  
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Cognitive Measures. 
In the 6-week trial, the Brief Assessment of Cognition in Schizophrenia (BACS; 
Keefe et al., 2004) was administered to assess neurocognition. The BACS is an instrument 
that assesses verbal memory, working memory, motor speed, attention, executive functions 
and verbal fluency in schizophrenia. In the 12-week trial, the Repeatable Battery for the 
Assessment of Neuropsychological Status (RBANS; Randolph, 2007) was administered to 
assess neurocognition. The RBANS measures immediate and delayed memory, attention, 
language, and visuospatial skills. 
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          CHAPTER III 
  Data Analytic Plan 
Preliminary Analyses Overview 
Descriptive statistics were used to evaluate baseline differences between the oxytocin 
(OT) and placebo (PL) groups.  Specifically, Multivariate Analysis of Variance (MANOVA) 
was used to evaluate differences on demographic, symptoms, compliance, social cognitive 
and neurocognitive variables for all 19 participants included in the analyses (OT, n=10; PL, 
n=9). There was one participant in the OT group who was erroneously given a placebo vial 
rather than an OT vial after his four-week visit.  This participant was not included in the 6-
week analyses since as-received rather than intent to treat analyses were conducted.   
Linear regression analyses were used in each of the primary, exploratory and post-hoc 
analyses to evaluate the predictive effect of group on each of the outcome variables at 6 
weeks. Baseline scores on each of the measures were first added as predictors in the linear 
models for all analyses so as to control for baseline performance. This allowed for an 
examination of the additional variance explained for by group (OT versus PL) when added to 
the model. Then, group was added as a second predictor using the codes 0 and 1 for the PL 
and OT group, respectively.  
Because significant group effects might not be detected due to a small sample size, 
within group changes were also analyzed. Within group paired samples t-tests were 
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conducted for the OT and PL groups separately for all primary, exploratory and post-hoc 
analyses.  To assess whether OT compliance was related to performance, Pearson two-tailed 
correlations were conducted between average compliance over the course of 6 weeks 
(average compliance for weeks 2, 4 and 6) and change scores (change scores computed by 
subtracting 6-week performance from baseline scores) on the 6-week social cognitive, social 
functioning and symptom measures for both conditions.   
Statistical significance was set at an alpha level of .05 or below and SPSS was used 
for all analyses.  Cohen’s d effect sizes were also calculated to measure the magnitude of 
treatment effects for within and between group analyses (Cohen, 1988). For within group 
effect size analyses, the correlation between the baseline line and 6- week score was included 
to correct for dependence between the two means. For the between group effect size 
analyses, the pooled standard deviation and least square means were used to calculate 
Cohen’s d. The specific primary hypotheses and exploratory aims are detailed below: 
Primary Analyses 
Hypothesis 1: It was hypothesized that OT will improve recognition of fear and 
anger in schizophrenia.  
To evaluate the first hypothesis, linear regression models with total correct responses 
for fearful and angry faces were entered as the outcome variables.  Paired samples t-tests 
were then conducted to evaluate changes within the PL and OT groups for fearful and angry 
faces. 
Hypothesis 2: It was hypothesized that OT will improve cognitive ToM as 
measured by the Brune Task and affective ToM as measured by the Eyes Test.   
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To test hypothesis 2, a linear model was conducted with total mental states correctly 
identified on the Eyes Test as the outcome variable. Within group analyses were similarly 
conducted to assess change in Eyes Test accuracy within each of the groups.  
To assess change in performance on cognitive ToM as measured by the Brune task, a 
series of linear regression models were conducted with total Brune score at 6-weeks and 
subscores (i.e., 1st order ToM, second and third order, deception, and reciprocity detection) as 
the outcome variables.  Then, within group analyses were conducted to evaluate change from 
baseline to 6-weeks for each of the aforementioned Brune scores.   
Hypothesis 3: It was hypothesized OT would improve self-reported empathy, as 
well as empathic ratings on a role-play measure.  
To assess whether OT improves empathy, a series of linear regression models were 
conducted with the 6-week IRI sum score and each of the four subscale scores (perspective 
taking [PT]; empathic concern [EC]; fantasy [F]; and personal distress [PD]) as the outcome 
variables.  Paired samples t-tests were conducted to assess change over time within each of 
the groups for the IRI total and subscale scores. The sample size for the IRI was smaller than 
other measures because the instrument was added after the study began. Thus, the total IRI 
sample is n=15 (OT, n=7; PL, n=8).  Because of the smaller IRI sample size and low internal 
consistency for the PT subscale at BL and Distress subscale at BL and 6-weeks, these results 
are more descriptive and should be interpreted carefully.  
In order to evaluate the preliminary psychometric properties of the empathy-rating 
scheme (a new behavioral measure of empathy), the reliability and validity of the instrument 
was assessed. First, the inter-rater agreement was evaluated using a two-way random effects 
Intra-Class Correlation (ICC) analysis. Convergent validity was explored with pearson 
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correlational analyses of the empathy rating scale and the Eyes Test and IRI subscales. 
Lastly, the internal consistency of the measure was evaluated with Cronbach’s alpha. 
Pending adequate validity and reliability, linear regression analyses were then conducted on 
each of the empathy items, as well as a sum score.  Paired samples t-tests were calculated to 
evaluate within group changes on the empathy-rating scheme.   
Hypothesis 4: It was hypothesized that OT will be related to greater ratings of 
trustworthiness.  
 Lastly, a linear regression model was conducted to assess whether OT predicts 
overall increased trustworthiness ratings at 6-weeks. The dependent outcome on the 
Trustworthiness Task was the mean trustworthiness rating across all 42 faces. Additionally, 
trustworthy judgments on two subscales were analyzed. As was discussed earlier, the mean 
ratings of “trustworthy” faces [i.e., top third of the most trustworthy faces (score of +1 or 
greater)] and “untrustworthy” faces [i.e., bottom third of untrustworthy faces (score of -1 or 
below)] based on Adolph et al.’s (2008) normative sample, were entered into linear 
regression models as outcome variables. Paired samples t-tests were then executed to 
evaluate within group changes on total trustworthy judgments, as well as mostly trustworthy 
and untrustworthy faces.  
Exploratory Analyses 
Exploratory Aim 1: Evaluate effect of OT on attributional style. 
 Exploratory Aim 1 was similarly assessed with linear regression models with AIHQ 
as the outcome variable. Specifically, the hostility and aggression bias scores (mean rating 
across two raters) and blame bias (average of the intentionality, anger and blame Likert scale 
items for each scenario) were entered into the model with baseline performance and group as 
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the predictors.  Paired samples t-tests were conducted to examine within group effects for the 
OT and PL groups. 
Exploratory Aim 2: Evaluate effects of OT on social and community functioning. 
To address exploratory Aim 2, a linear regression was conducted with social 
functioning as measured by ratings on a social skill role-play as the outcome variables. 
Consistent with previous studies (e.g., Pinkham et al., 2007), role-play ratings were 
combined into three composite scores: global social skill (content, social anxiety, overall 
social skill items), specific skills (clarity, fluency, meshing, involvement and question items), 
and non-verbal skills (gaze, appropriate affect, and flat affect items). The social skill 
composite scores for the two role-plays (i.e., “getting to know your neighbor” and the 
empathy role-play) were analyzed with t-tests to determine if they should be collapsed or 
analyzed separately (i.e., if the composite scores for the two role-plays were significantly 
different, then between and within group analyses would be conducted separately for each of 
the role-plays).  
In addition to the social skills role-play ratings, a subjective measure of social and 
community functioning was measured with the SLOF participant and informant 
questionnaires.   A social subscore was created on the SLOF using the sum of socially 
relevant SLOF subscales, (interpersonal relationships and social acceptability subscales).  In 
addition to the social subscore, the total SLOF score was analyzed to assess overall 
community functioning. Both the social subscore and the total score were entered into 
separate linear regression analyses as the dependent variables, with baseline performance and 
group as the predictor variables. Note that the SLOF was included after the study began; 
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therefore, it was not collected for three of the 6-week participants and not collected at the 6-
week visit for the five 12-week participants; thus, the sample size is smaller for the SLOF 
analyses (OT, n=6; PL, n=5).  
Exploratory Aim: Moderator and Mediators of OT effects on social cognition. 
Lastly, as part of the post-test analyses, the potential mediators and moderators of OT 
were evaluated. Specifically, one aim was to evaluate whether gender moderates the 
relationship between OT and social cognition. An additional aim was to investigate the 
possible mediating effects of anxiety and neurocognition on social cognition.
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CHAPTER IV 
Results 
Descriptive Analyses 
The study groups did not differ on demographic variables (Table 2), baseline 
dependent measures (Tables 3, 5-7), or on medication compliance ([OT average 
compliance=77.61%; SD=34.10); PL (average compliance=77.26%, SD=16.75)], F(1, 
16)=.001, p=.98). (Note: the compliance data for one OT participant was not collected.)  
Additionally, three participants who completed baseline visits did not complete six-week 
visits. These three participants did not differ on baseline demographic variables from the 19 
participants included in the current analyses.  
Primary Analyses:  Social Cognitive 6-week analyses 
Emotion Recognition.  
Between group analyses. 
In order to evaluate the effect of OT on fear and anger recognition at 6 weeks, linear 
regression analyses were conducted. When baseline performance and group were entered as 
predictors into the model, there was no significant effect of treatment group on fear or anger 
recognition (see Table 3 for raw means, least square means and unstandardized B 
coefficients).  Subsequent post-hoc analyses were conducted to evaluate the effects of OT on 
other emotions (sad, happy, no emotion; Table 3) and on intensity of emotional expression 
(mild and extreme intensity; Table 3).  Post hoc analyses revealed that the OT condition 
showed a trend level improvement in the recognition of faces displaying high intensity 
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emotions [Group B=.65 (95%CI: -.10-1.40), R2=.86, p=.085]; the effect size for this 
difference was large. Specifically, the OT group showed a .65 increase in recognition of high 
intensity emotions at 6-weeks as compared to the PL group. There were no significant 
changes in the other emotion recognition outcome variables for either group (Table 3).  
Within-group analyses. 
There were no significant with-in group changes for either group for fear or anger. 
Post hoc within group analyses revealed a significant improvement in recognition of faces 
with higher (i.e., extreme) intensity emotions in the OT group (t(9)=-2.53, p=.035) and not in 
the PL group. Effect sizes reflected a large improvement in the recognition of higher 
intensity emotions for the OT group.  Post-hoc analyses revealed no changes on other 
emotions or mild intensity faces for either group (Table 3).  
Theory of Mind (ToM): Affective and cognitive ToM. 
Between group analyses. 
There was no significant treatment group effect on affective ToM as measured with 
the Eyes Test. Similarly, there were no treatment group effects on cognitive ToM as 
measured by the Brune Task. (See Table 3 for total score and subscore raw means, least 
squares means, and unstandardized B coefficients). 
Within-group analyses. 
There were no within group changes on the Eyes Test for either group (Table 3). The 
OT group significantly improved on overall cognitive ToM as measured by total score on the 
Brune task (t(9)=2.33, p=.045). Specifically, the OT group showed a large improvement in 
overall Brune performance. However, the OT group was still performing worse than the PL 
group at 6 weeks. The OT group also displayed a significant improvement in detection of 
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deception (t(9)=3.00, p=.015); whereas the PL group did not significantly improve.  The 
effect size for improved deception detection was large in the OT group and moderate in the 
PL group. In addition, the OT group showed a trend level improvement on 2nd order ToM 
(t(9)=2.09, p=.066).  Similar to the other Brune results, the effect size for improved 2nd order 
ToM was large in the OT group and small to moderate in the PL group (the OT group was 
still performing slightly worse than the PL group at 6-weeks).  The PL group showed a trend 
improvement on 1st order ToM (t(8)=1.89, p=.095); whereas no significant change was seen 
in the OT group (t(9)=.94, p=.373). The effect size for improved 1st order ToM was moderate 
in the PL group and small in the OT group. Neither group showed significant changes in 3rd 
order false belief or reciprocity detection (Table 3).  
Social Perception. 
Between group analyses. 
There was no effect of treatment group on social perception, as measured by 
trustworthiness judgments. Additional linear regression analyses were conducted to evaluate 
change on two trustworthiness subscores: faces judged as mostly trustworthy and as mostly 
untrustworthy by nonclinical samples using Adolph et al.’s (2008) normative sample. There 
were no significant effects of group on either of the two trustworthy subscores; however 
there was a moderate increase in rating untrustworthy faces as more trustworthy in the OT 
group relative to the PL group  [Group B=6.44; R2= .205, p=.174]. The OT group showed a 
6.44 increase in trustworthiness ratings for faces typically rated as untrustworthy as 
compared to the PL group. (See Table 3 for raw means, least square means, and 
unstandardized beta coefficients.)  
Within group analyses. 
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Similarly, there were no significant within group changes on the total sum ratings on 
the trustworthiness task or two subscores for either group; although, the OT group’s effect 
size was in the expected direction for ratings of all faces and the untrustworthy faces. 
Specifically, the OT showed a small increase in trustworthiness judgments for untrustworthy 
faces (i.e., rating untrustworthy faces as more trustworthy; t(9)=.87, p=.406), while the PL 
group showed a small decrease in trustworthiness judgments for the same faces (i.e., rating 
the untrustworthy faces as less trustworthy; t(8)=-.50, p=.630) (Table 3).  
Empathy: Interpersonal Reactivity Index (IRI). 
Between group analyses. 
The impact of OT on self-reported empathy, as measured by ratings on the IRI, was 
analyzed. There was a statistically significant improvement of self-reported perspective 
taking in the OT group [Group B=4.30; R2= .780, p=.022].  That is, the predicted value of 
perspective taking increased by 4.30 units at 6 weeks for the OT as compared to the PL 
group. Furthermore, group (OT, PL) explained 12.7% of the variance in self-reported 
perspective-taking1. The effect size was large for the improved perspective-taking in the OT 
group as compared to the PL group. There were no significant effects of treatment group on 
the other IRI subscores (fantasy, emotional concern, distress) or total score (Table 3).   
Within group analyses. 
Within group paired samples t-tests showed significantly improved perspective- 
taking in the OT group at 6-weeks (Table 3; t(6)=-2.68, p=.037). Moreover, the effect size 
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was large for improved perspective-taking in the OT group. The OT group also showed a 
trend level decrease in self-reported emotional empathy (t(6)=2.189, p=.07), with a large 
decrease in self-rated emotional empathy. OT was not related to any other changes on the 
IRI. The placebo group showed a significant decrease in self-reported distress (t(7)=3.48, 
p=.010). The PL group also showed a trend level decrease in total self-reported empathy 
(t(7)=2.00, p=.085). Specifically, the PL group displayed a large decrease in total self-
reported empathy at six-weeks (Table 3).  
Empathy: Role-play. 
Psychometric Properties. 
The initial psychometric properties of a new behavioral rating scheme of empathy 
were evaluated.  Two raters, blind to group status, were trained to reliability on 13 cases.  
They achieved Inter Class Correlations (ICCs) !.60 on four of the five empathy role-play 
items: Emotional empathy ICC=.60; cognitive empathy ICC=.66; ideomotoric empathy 
ICC=.60; helpfulness ICC=.50; summary empathy item ICC=.75. (Note, 16 of the cases in 
the present study were rated by one of the raters.) Since the helpfulness item did not reach 
acceptable levels of inter-rater reliability, it was excluded from the analyses. Internal 
consistency of the four remaining items (cognitive, emotional, ideomotoric, and the summary 
empathy item) was then evaluated. The empathy role play showed a reasonable level of 
internal consistency (Cronbach's alpha=.60).  The average correlation between the four 
empathy items was .28 (range of item correlations: .05-.58; Table 4). The four empathy items 
were positively correlated with the total empathy score (sum of the empathy items). The 
cognitive empathy role-play item was significantly correlated with the summary item (i.e., 
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participants with higher rated cognitive empathy displayed higher ratings on the overall 
empathy summary item).  
In regard to convergent validity with the IRI, the ideomotoric empathy role play item 
had a trend positive correlation with the IRI-Total score (p=.07); participants with higher 
ideomotoric ratings on the role-play reported higher overall empathy on the IRI. In addition, 
there was a trend positive correlation between the total role-play empathy score and total IRI 
score (p=.11). That is, participants with higher ratings on the empathy role-play measure 
reported higher levels of empathy. There were no other significant correlations between the 
other empathy role-play items, IRI subscales or the Eyes Test (Table 4).  
Between group-analyses. 
Between group differences at 6 weeks were evaluated for each item on the empathy 
role-play and the total empathy score.  There was no significant effect of treatment group on 
the empathy role-play; however, there was a trend for group to be a significant predictor of 
emotional empathy [B=.571, R2=.352, p=.086].  Specifically, the OT group was trending 
towards higher emotional empathy scores at 6-weeks relative to the PL group, with a larger 
emotional empathy rating observed in the OT group as compared to the PL group. The effect 
sizes were in the expected direction (i.e. improvements for the OT group over time) for all 
empathy items (Table 5). 
Within group-analyses. 
Within-group analyses revealed no significant changes for either group at 6 weeks on 
the empathy role-play items or total score (Table 5).   
Exploratory Analyses  
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Social and Community Functioning. 
Social skill role-play: psychometric properties.  
Two independent raters, blind to group status, were trained to reliability on 13 cases. 
They reached acceptable levels of reliability for social skill ratings on both role-plays [i.e., 
ICCs !.60; Role play 1 (“getting to know your neighbor”):  Global ICC=.70, Specific skills 
ICC=.94, Nonverbal ICC=.63 and Role play 2 (empathy role-play): Global ICC=.74, Specific 
skills ICC=.80, Non verbal ICC=.60]. Note: one rater rated 16 of the cases in the present 
study. 
Comparisons between the two role-plays were conducted to determine whether to 
collapse them in the analyses.  Since the global social skill ratings for role-play 1 and 2 were 
significantly different at baseline [Role Play 1 Mean (SE)=10.75(.37), Role Play 2 Mean 
(SE)=11.83(.20), t(19)=-3.228, p=.004], the role-plays were analyzed separately for the 
subsequent analyses.  
Between group analyses. 
Linear regression analyses revealed that group was a significant predictor of global 
social skills for role-play one [B=1.08, R2=.461, p=.042]. That is, the predicted value of 
global social skills for role-play one increased by 1.08 units for the OT as compared to the 
PL group. Specifically, group (OT, PL) explained 16.5% of the variance in global social skill 
for the first role-play2.  Regarding the effect size, the OT group showed larger global social 
skill ratings compared to the PL group at the 6-week visit.  Similarly, group was a significant 
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predictor of global social skills for role play two [B=1.32, R2=.553, p=.05]. That is, 
participants in the OT showed larger global social skills ratings for role-play 2; the predicted 
value of global social skills for role-play two increased by 1.32 units at 6 weeks for the OT as 
compared to the PL group. Group explained 12.6% of the variance in global social skills for 
role-play 23. Group was not a significant predictor for any other 6-week social skill 
components (Table 5). 
Within group-analyses. 
 The OT group showed a trend improvement in global social skills ratings for role 
play1 (t(9)=2.108, p=.06); the effect size indicated a large improvement in global social skills 
ratings at 6 weeks. On the contrary, the PL group showed a significant decrease in global 
social skills ratings (t(8)=  -.858, p=.021) and non verbal social skill ratings (t(8)=-2.296, 
p=.05) for role play 2.  The effect sizes indicated that the PL condition had a large decrease 
in their global and nonverbal social skills ratings at the 6-week visit.  There were no other 
changes observed in either group (Table 5). 
SLOF. 
Between group analyses. 
Analyses were conducted evaluating changes on community and social functioning as 
measured by informant and participant ratings on the SLOF.   There was no effect of 
treatment group on the SLOF community or social functioning (Table 6). 
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Within group analyses. 
Within group analyses in the OT group revealed a significant improvement on the 
total SLOF score (t(5)=2.882, p=.045) and the social subscore (t(5)=2.697, p=.05) for 
participant ratings and no changes for the informant SLOF ratings; however the SLOF 
participant effect sizes were large in both the OT and PL groups (Table 6). 
Attributional style. 
Between group analyses. 
Exploratory analyses were conducted to test the effects of OT on attributional style. 
There was no effect of group on AIHQ aggression, hostility or blame bias and the effect size 
analyses indicate no differences between the groups at the 6 week visit (Table 6).  
Within group analyses. 
The OT group did not show within group changes on AIHQ aggression, hostility or 
blame bias scores at 6-weeks. The placebo group showed a significant decrease in AIHQ 
hostility (t(8)=-3.125, p=.014) and blame biases (t(8)=-2.53, p<.05) (Table 6). Specifically, 
the PL group had a large decreases in hostility and blame bias scores at 6-weeks. Although 
non-significant, the OT group demonstrated moderate decreases in hostility and blame biases 
(Table 6).  
Mediation & Moderation Analyses 
 An additional exploratory aim was to evaluate whether anxiety and neurocognition 
mediate the relationship between OT and treatment effects.  Baron and Kenny’s (1986) 
approach to mediation involves conducting three regression analyses, if all three are 
significant, then Sobel’s Test (1982) is conducted. There was no significant effect of OT on 
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self-reported anxiety, as measured by the LSAS, between groups [B=.506 (SE=11.18), 
R2=.513, p=.964) or within the OT group [t(9)=1.611, p=.142] and no effect of OT on the 
PANSS anxiety item between groups [B=.517(SE=.600), R2=.273, p.=401] or within the OT 
group [t(9)=.537, p=.604]. Therefore, the analysis evaluating anxiety as a mediator of OT 
treatment effects was not supported.  Although neurocognition was collected at baseline and 
6-weeks for only 10 participants, changes in neurocognition were still explored. A linear 
regression analysis revealed no effect of group on neurocognition at 6 weeks as measured the 
total BACS score [B=1.76 (SE=4.69), R2=.746, p=.721] and no within-group change in 
neurcognition for the OT condition [t(4)=.535, p=.621]. Therefore, no further analysis of 
neurocognition as a mediator was warranted. An insufficient sample of women (i.e., 3 
females/19 participants) precluded exploring gender as a moderator. 
Post-Hoc Analyses 
Symptom measures: 6-week analyses. 
Between group analyses. 
Post-hoc analyses were conducted to evaluate the effects of OT on clinical symptoms. 
Linear regression analyses showed a significant effect of group on negative symptoms. 
Specifically, the OT group had a significant decrease in negative symptoms at 6 weeks 
compared to the placebo group (B =-3.78, R2 =.412, p=.046). The predicted value of negative 
symptoms at 6 weeks decreased by 3.78 units for the OT group as compared to the PL group. 
To determine the additional variance that group contributed when added to the model, the 
variance for the model with only baseline negative symptoms was subtracted from the 
variance for the entire model (BL negative symptoms and group); treatment group explained 
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17.2% of the variance in week 6-negative symptom scores4.   The effect size showed a large 
decrease in negative symptoms for the OT group as compared to the PL group. There was no 
effect of group on the total PANSS score, other PANSS subscores (i.e., positive and general 
symptoms), the PANSS anxiety item, or self-reported anxiety as measured by the Liebowitz 
Social Anxiety Scale (Table 7). 
Within group analyses. 
Within group analyses revealed significant changes over time for the OT group.  The 
OT group had a significant decrease on the PANSS total (t(9)=-3.63, p=.006) and all PANSS 
subscores [(positive: t(9)=-3.42, p=.008; negative: t(9)=-4.83, p=.001; general 
psychopathology: t(9)=-2.27, p=.05)] at 6 weeks (Table 7).  The placebo group showed a 
significant decrease in PANSS positive (t(8)=-2.95, p=.018) and general psychopathology 
(t(8)=-2.70, p=.027) subscores, as well as the PANSS anxiety item (t(8)=-2.63, p=.03); 
however there were no changes on the PANSS total or PANSS negative subscores.  There 
was also no change on the Liebowitz Social Anxiety Scale for either group (Table 7).  
The effect size analyses revealed a large decrease in negative symptoms for the OT 
group. The PANSS total score effect size was large in the OT group and moderate in the PL 
group. The effect sizes were large for both groups on PANSS positive symptoms and 
PANSS-general scores (Table 7). 
Compliance and change scores 
!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!! !!!!!!!!!!!!!!!!!!
&(R2 BL negative symptoms, Group=.412)-(R2 BL negative symptoms=.240)=.172 
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Post-hoc correlational analyses were conducted to evaluate the relationship between 
study drug compliance and change scores on the social cognitive, social and community 
functioning measures, as well as symptom measures. Correlations between mean compliance 
over the 6 weeks and change scores revealed significant negative correlations between 
compliance and change in AIHQ Blame scores, PANSS-general symptoms, a significant 
positive correlation between compliance and overall empathy on the empathy role-play, as 
well as a trend level negative correlation with change in total PANSS scores for the OT 
group. That is, participants who were more compliant with OT showed a greater decrease in 
AIHQ blame bias, PANSS-general symptoms, increased overall empathy and a trend towards 
overall reduced symptoms (Tables 8-9). The PL group showed a significant negative 
correlation with the ER-40 change score; participants more compliant with the placebo were 
less accurate over time on the ER-40 (Table 8). Positive correlations with PL compliance and 
change on the cognitive empathy, empathy summary role-play item, as well as global social 
skills ratings for role-play 2 were also observed. Specifically, participants in the PL condition 
with greater improvements in cognitive empathy, overall empathy and global social skills 
were more compliant with the placebo (Table 9). There were no other significant 
relationships with compliance on social cognitive or symptom measures (Table 8) or role-
play items (Table 9). 
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   CHAPTER V 
Discussion 
This is the first multi-day RCT to assess the effects of OT on social cognition, social 
functioning and community functioning in individuals with a schizophrenia spectrum 
disorder.  It was hypothesized that OT would be associated with improvements in four social 
cognitive dimensions (emotion recognition, ToM, social perception and empathy). The 
results showed that participants randomized to the OT condition improved on self-reported 
cognitive empathy, cognitive Theory of Mind (ToM) and global social skills as compared to 
participants in the placebo condition. Post-hoc analyses revealed that OT was related to 
improved identification of intense facial emotions and a reduction in negative symptoms. 
These results are consistent with others who have found OT improves components of social 
cognition in schizophrenia (Averbeck et al., 2012; Guastella & MacLeod, 2012; Kuehn, 
2011; Rubin et al., 2011; Striepens et al., 2011).  
OT, however, was not related to improvements in all aspects of social cognition. 
There were no significant changes for fear or anger recognition, affective ToM, or social 
perception. These results suggest that OT may impact social cognition differentially, which is 
consistent with a recent review of the literature (Bartz et al., 2011). While the current study’s 
results must be tempered due to the small sample size, they are a contribution the limited 
literature examining OT treatment of social cognition in schizophrenia. A more detailed 
description of the results, limitations, implications and future directions are discussed below.  
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Cognitive Theory of Mind (ToM) 
One central finding was that the OT group demonstrated significant improvements on 
overall cognitive ToM, detection of deception and a trend level improvement on second order 
ToM as measured by the Brune card-sequencing task.  However, both groups did improve 
over time. The effect sizes were large in the OT group and moderate in the PL group for 
overall Brune score, deception detection and second-order ToM. It must also be noted that 
the PL group showed a trend improvement in first-order ToM. The OT group also improved 
on first-order ToM, but not as greatly as PL. Schizophrenia samples, however, have not 
shown to perform significantly worse on first-order ToM as compared to non-clinical 
samples (Brune 2005). Thus, first-order belief does not appear to be an area that needs 
remediation in schizophrenia. Overall, improvements were found in areas of cognitive ToM 
that have shown to be more compromised in schizophrenia as compared to non-clinical 
samples (Brune, 2005).  
The finding that the OT group displayed an improvement in deception detection is 
intriguing. The deception questions on the Brune task tap into the participant’s ability to 
accurately identify whether a character is trying to deceive another person who is unaware of 
the deceptive act (for example “what do you think the person in red intended to do?”). 
Improved deception detection implies that OT improves accurate discrimination of false and 
deceitful  intentions. The improvement in deception detection addresses concerns that OT 
could be exploited if it leads to a generalized increase in trust and would possibly make 
individuals vulnerable to exploitation (e.g., Penney and McGee, 2005). An ability to detect 
deception suggests otherwise; OT may therefore improve discriminating beliefs about others 
intensions.  
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Although there is little research on OT and deception detection, there was a recent 
study that may shed some light on these results (Krueger et al., 2012).  Krueger et al. (2012) 
used an experimental design to assess OT’s impact on attitudes towards perpetrators and 
victims in a non-clinical sample. The participants completed a series of vignettes involving 
criminals and their victims; participants were asked to rate the harm endured by the victim. 
Krueger et al. (2012) found that OT was associated with increased harm ratings as compared 
to a PL. Although the authors note that their findings suggest OT facilitated increased 
empathy towards the victims, their results may also point to an increased ability to detect 
deception (or harm, which was the prompt in their study). Perhaps OT increases 
understanding of others in distress and consequently accuracy in detecting when someone has 
been deceived or vice versa.  This proposition highlights the overlap between components of 
social cognition, such as ToM and empathy.  
Overall, the current study suggests a relationship between OT and cognitive ToM in 
schizophrenia. These results are promising for the treatment of social difficulties in 
schizophrenia. ToM, particularly cognitive ToM, is a robust correlate of functioning in 
schizophrenia (Fett et al., 2011). Indeed, the therapeutic potential of OT for ToM deficits in 
schizophrenia has started to gain attention and great interest. In one review, Biedermann et 
al. (2012) discuss OT’s promise in ameliorating ToM deficits and use as an adjunctive 
treatment with psychotherapeutic approaches.  
Affective ToM 
Contrary to what was hypothesized, the OT group did not show significant 
improvements on affective ToM; although, the OT and not the PL demonstrated effect sizes 
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in the expected direction (i.e., increased performance at 6-weeks compared to baseline for the 
OT group). This is surprising given that OT has lead to improved performance on the Eyes 
Test for non-clinical samples (Dome et al., 2007) and individuals with Autism (Guastella et 
al., 2010). Although OT has shown to be related to improved affective ToM as measured by 
the Eyes Test, improvements have not been seen on all affective ToM measures. For 
example, Hurlemann et al. (2010) did not find OT improved identification of guessing the 
mental states of characters in a non-clinical using the Multifaceted Empathy Task.  
Two possible explanations for not finding significant treatment effects on the Eyes 
Test will be discussed. First, there could be a subgroup of participants who could benefit 
from OT treatment. Second, there may be particular items on the Eyes Test that are sensitive 
to treatment effects (e.g., Domes et al., 2007; Luminet et al., 2011).  For example, Luminet et 
al. (2011) found that OT was related to improved performance on the Eyes Test for high 
alexithymia (a personality style characterized by trouble identifying one’s emotions) as 
compared to low alexithymia participants in a non-clinical sample.  Furthermore, the high 
alexithymia participants showed more pronounced improvements on high intensity and not 
low intensity stimuli. Since individuals with schizophrenia report higher levels of 
alexithymia  (Yu et al., 2011), the Luminet et al. study suggests that improvements on the 
Eyes Test may be detected if the intensity of the affective states presented was analyzed. 
Unfortunately, the intensity of affective states on the Eyes Test was not evaluated in the 
current study since there are no established subscales based on affective intensity. (Luminet 
et al. independently created subscales in their study.) Lastly, there may be a subset of 
individuals with schizophrenia whose affective ToM would improve with OT treatment (e.g., 
those with increased alexithymia).  
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Empathy 
Consistent with the finding of improved cognitive ToM, self-reported perspective-
taking increased in the OT group (cognitive component of empathy); whereas, the placebo 
group showed a significant decrease in empathic distress and overall trend towards decreased 
self-reported empathy. The improvement in perspective-taking component of empathy is 
promising given that schizophrenia samples have repeatedly shown deficits in self-reported 
perspective-taking as compared to non-clinical samples (Achim et al., 2011; Haker & 
Rossler, 2009; Montag, Heinz, Kunz, & Gallinat, 2007; Shamay-Tsoory, Aharon-Peretz, et 
al., 2007). There are no other studies evaluating OT and perspective-taking in schizophrenia; 
however, improved empathy has been found in non-clinical samples administered OT  (Bartz 
et al., 2010). It should be noted, however, that the IRI was implemented after the study began 
and only 15 participants completed the measure.  In addition, the IRI perspective-taking 
subscale at baseline and the distress subscale at baseline and 6-weeks demonstrated poor 
internal consistency. Therefore, these results must be interpreted cautiously.  
The perspective-taking items on the IRI tap into an individual’s perception of their 
ability to take the viewpoint of another person (e.g., “Before criticizing someone, I try to 
imagine how I would feel if I was in their place”). The improved empathic perspective-taking 
is indeed promising.  As noted, individuals with schizophrenia report deficits in this 
component of empathy. These deficits have shown to worsen as the illness progresses 
(Achim et al., 2011; Montag et al., 2007) and appear to be independent of symptoms (Smith 
et al., 2012).  Furthermore, self-reported perspective taking has been associated with 
community functioning in schizophrenia (Smith et al., 2012) and so this may be an important 
area to target in treatment.  
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Another finding was that individuals in the OT group showed a large decrease in the 
emotional concern component of empathy; this is consistent with evidence that empathy is 
multidimensional (Adolphs, 2009).   And, a decrease in emotional concern may not be 
surprising. The somewhat paradoxical effects of OT have been seen in other studies where 
increases in non-prosocial emotions are observed (Bartz et al., 2011); for example, Shamay-
Tsooray et al. (2009) found that OT was related to increased envy in a non-clinical sample.  
Another possibility for observing differential effects on components of empathy may be 
related to dosing. Other studies evaluating OT and empathy have in fact found the effects on 
empathy are sensitive to the dose of OT administered (e.g., Hurlemann et al., 2010). 
Hurlemann et al. (2010) assessed cognitive and emotional empathy in a non-clinical sample. 
Hurlemann and colleagues found emotional empathy, as measured by the Multifaceted 
Empathy Task (MET), increased in the lower (24 IU) but not higher OT doses (48 IU). The 
authors suggest that higher OT doses may desensitize OT receptors and thereby influence the 
effects of OT on emotional empathy.  
Objective Empathy 
In addition to evaluating empathy with a self-report measure, a new objective 
measure of empathy was developed and assessed. The new behavioral measure of empathy 
and corresponding rating scheme demonstrated satisfactory initial psychometric properties.  
Interestingly, there was a trend relationship between overall empathy score and overall self-
reported empathy on the IRI for the total sample. This suggests that the rating-scheme and 
IRI are tapping into a similar construct. A strength of the rating scheme is that it accounts for 
the multidimensional nature of empathy, which no other current rating scheme of empathy 
accomplishes. Others have noted the need for behavioral measures of empathy (Smith et al., 
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2012) and thus this rating-scheme may be a necessary compliment to the current measures 
used to evaluate empathy.  
There were, however, no significant changes in objective empathic behavior as 
measured by the behavioral measure of empathy.  Although not significant, there was a trend 
level increase in emotional concern for the OT group (i.e., higher rated emotional concern 
exhibited in the empathy role-play).  This finding is interesting given that improvements 
were observed in self-reported cognitive but not emotional empathy on the IRI.  Perhaps 
improvements in self-rated cognitive empathy (i.e., perspective taking) translate to increased 
emotional concern displayed in social interactions.  
Social Skills 
The OT condition displayed a large improvement in social skills, namely global 
skills. The global component consists of overall social skill, content (e.g., appropriateness of 
the content to the discussion) and overall social anxiety. Interestingly, compliance was not 
related to social skills performance for the OT condition, rather compliance was related to 
performance for the PL condition.  
 Studies evaluating the effects of OT on social functioning have used paradigms 
similar to the social skills task used in the present study (e.g., Ditzen et al., 2009; Hall et al., 
2012). These studies have found that certain aspects of social skills, as measured by 
performance-based measures, improve with exogenous OT. In a recent study, Hall et al. 
(2012) found eye gaze increased following 24 IUs of OT and decreased social anxiety after 
48 IUs of OT in individuals with Fragile X syndrome (a condition associated with 
interpersonal difficulties). In another social skills and OT study, Ditzen et al. (2009) found 
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one 40 IU dose of OT was related to an increase in overall positive behavior (positive 
behavior defined as eye contact, agreement, nonverbal positive behavior, etc.) for couples 
during a role-play conflict compared to those given a placebo.  Thus, there is some 
preliminary evidence that OT can improve social functioning at an observable level.  
In the current study, significant changes were seen in global skills and not in 
nonverbal or specific social skills. Changes in global skill may be more apparent during a 
shorter role-play (90 seconds) than other aspects of social skills. Both role-plays in Hall et al. 
(2012) and Ditzen et al. (2012) were 10 minutes long; it may have been more difficult to 
observe treatment effects in subtle nonverbal behavior and specific social skills (e.g., eye 
gaze) during the 90-second role play that was used in the current study.   
Global social skills are critical elements for successful interactions.  The mechanism 
of change for improved social skills in the current study is unknown.  OT may improve 
aspects of social cognition, such as ToM and empathy, that in turn improve overall social 
skills.  This proposition is consistent with findings that social cognition is a robust predictor 
of social functioning (Fett et al., 2011).  The improvement in global social skills is certainly a 
central finding in the current study.  Furthermore, the effect size for global social skills in the 
OT group is similar to the effect sizes found for psychosocial treatments targeting social 
functioning [see Kurtz and Mueser’s (2008) meta-analysis of social skills interventions in 
schizophrenia].  Overall, these results are preliminary evidence that OT improves social 
functioning in schizophrenia. 
Emotion recognition 
 High intensity emotions. 
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Post-hoc analyses revealed significant improvements in the recognition of faces with 
extreme emotional intensity in the OT group. These results are consistent with studies 
demonstrating that identification of extreme emotions is more difficult for individuals with 
schizophrenia (Kohler et al., 2003) compared to non-clinical samples and others that have 
found OT affects perception of emotional intensity in schizophrenia (Goldman et al., 2011).  
Specifically, Kohler et al. (2003) found that individuals with schizophrenia have more robust 
difficulties in identification of extreme emotions as compared to non-clinical controls. Kohler 
et al. do not postulate why extreme emotions would be more compromised for individuals 
with schizophrenia; but, it is possible that extreme emotions may increase arousal and 
distress, which has been linked to decreased emotion recognition (Morris et al., 2009). 
Additionally, a recent study evaluating the effects of OT on emotion recognition in 
schizophrenia found that OT resulted in decreased intensity ratings of emotions (i.e., 
Goldman et al., 2011).  Although participants were not rating the intensity of emotions in the 
current study, the present results and Goldman et al.’s findings suggest that OT may impact 
perception of emotional intensity.  
Fear and anger recognition.  
There was no change in recognition of fear and anger as was hypothesized. These 
results are not consistent with others who have found OT is associated with improved 
emotion recognition of fear in individuals with schizophrenia (Averbeck et al., 2012; 
Goldman et al., 2011) and anger in non-clinical samples (Fischer-Shofty et al., 2010).  Given 
that recognition of negative emotions, such as fear, is impaired in schizophrenia (Gur et al., 
2007), it is surprising that no effect was seen on recognition of these emotions after 6 weeks 
of OT treatment.  
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There have only been two published studies that have evaluated OT and emotion 
recognition in schizophrenia (Averbeck et al., 2012; Goldman et al., 2011). Averbeck et al. 
(2012) found an overall improvement in emotion recognition and a trend towards 
significantly improved fear recognition using a subset of Ekman’s faces after one 24 IU OT 
dose. As discussed earlier, Goldman et al. (2011) found that a higher dose (20 IU) of OT, but 
not a lower dose (10 IU), increased emotion recognition accuracy. Specifically, the 
improvements in their study were found for fearful faces in a polydipsic schizophrenia 
sample. In fact, they found that 10 IUs actually decreased accuracy in affect recognition in 
participants.  
The results of Averbeck et al. (2012) and Goldman et al. (2011) suggest that OT may 
only target specific emotions, particularly fear. In addition, it seems that emotion recognition 
is sensitive to OT dosage and may be ameliorated in certain individuals with schizophrenia. 
In comparing these two studies with the present study, it is interesting to consider whether 
dosage did indeed impact the results in the present study.  Perhaps there is a curvilinear 
dosage response where no treatment effect (or worse performance) is seen in low and higher 
levels of intranasal OT. (Note, participants were administered approximately 24IUs of OT 
daily for six-weeks in the current study.)  
Aside from differences in dosage, inconsistencies in study designs may account for 
discrepant results (Bourke et al., 2010).  One major difficulty in comparing across studies is 
that the stimuli administered are not constant.  Whereas the current study used the ER-40, 
others have used different facial stimuli, such as the Ekman faces (e.g., Averbeck et al., 
2012; Goldman et al., 2011); although, the Ekman faces task is not as psychometrically 
sound as the ER-40 (see Carter et al., 2009). In addition, stimuli differ in their presentation. 
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Some are static (such as the stimuli in the present study), while others have used morphed 
faces (e.g., Fischer et al., 2010).  However, Averbeck et al., (2012) evaluated the effects of 
OT on morphed and unmorphed faces, and did not find a difference in performance. Another 
important point is that the duration of the stimuli varies, with some presenting for an 
unlimited amount of time (Goldman et al., 2011) and others where the stimuli are time- 
limited (Averbeck et al, 2012). It would behoove researchers to replicate emotion recognition 
results using the same stimuli and methods across studies. This would elucidate the effects of 
OT on emotion recognition and help build a more consistent body of evidence. 
Social Perception 
The hypothesis that OT would impact social perception as measured by 
trustworthiness judgments was not supported, although there was a moderate (non 
significant) increase in rating untrustworthy faces as more trustworthy in the OT group.  The 
only other study to assess OT’s impact on trustworthy ratings in schizophrenia was Pedersen 
et al. (2011). Pedersen et al. found a trend towards increased ratings of trustworthiness for 
untrustworthy faces after two-weeks of OT.  
Other researchers evaluating the effect of OT on social perception have found mixed 
results (Bartz et al., 2011). Specifically, OT has been associated with increased 
trustworthiness (Kosfeld et al. 2005; Theodoridou et al., 2009) in non-clinical samples. On 
the contrary, others have found it has actually been associated with increased mistrust in 
certain populations (e.g., Borderline Personality Disorder; Bartz et al., 2010). A recent meta-
analysis found that OT was related to increased trust for in-group members and there was no 
effect on trust of out-group members (Van Ijzendoorn & Bakermans-Kranenburg, 2011).  
This implies that the effect of OT on social perception, particularly trust, is nuanced.  
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One reason for not observing significant and larger changes in social perception may 
be related to the measure of trustworthiness.  Perhaps the current study’s trustworthiness 
design did not tap into real-world trusting behavior; other studies that have found a 
significant relationship between OT and trust behavior in schizophrenia (e.g., sharing a secret 
paradigm in Keri et al., 2011) and non-clinical samples (e.g., Zak et al., 2005) have used 
more ecologically-valid measures. Zak et al. (2005) found OT was related to trust behavior in 
a non-clinical sample using a cash transfer paradigm. Specifically, the OT group was more 
trusting when they received money from a person who had chosen a certain amount to give 
as compared to when they received an amount that was randomly chosen. Thus, intention 
may be important in impacting trusting behavior, which was not assessed in the current 
study. This suggests that OT may be implicated in reciprocal trust rather than generalized 
trusting behavior.  In sum, further research is necessary to better understand the relationship 
between OT and trust behavior in schizophrenia. Future studies should consider utilizing 
more complex and ecologically valid social perceptual measures that assess intention.  
Attribution Style 
The current study also explored the relationship between OT and attribution style. 
There was no specific effect of OT on attribution style. Instead, both groups showed 
moderate to large decreases in blame and hostility biases.  In addition, compliance was 
significantly associated with AIHQ blame bias in the OT condition. That is, greater OT 
compliance was related to a greater reduction in blame bias--underscoring the importance of 
accounting for compliance in OT trials.  
Subjective social and community functioning 
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Additional exploratory aims were to evaluate OT’s effects on self-reported social and 
community functioning.  Although within group increases in social and community 
functioning were observed in the OT group, the PL condition also showed moderate to large 
improvements in these areas.  It is noteworthy that the OT group had slightly higher scores 
on the SLOF at baseline and still improved on social and community functioning (the 
opposite of what one would expect if regression to the mean was present).  
It should be noted that a limited sample completed the SLOF at baseline and 6-weeks 
(n=11) because the measure was not collected at six-weeks for the participants in the 12-
week trial and was not collected for three of the 6-week participants.  It is possible that a 
longer duration than six-weeks is needed to observe treatment effects on community 
functioning. Regardless, future OT research should consider including the SLOF given its 
relationship to social cognition (Smith et al., 2012) and social functioning (Bowie et al., 
2007). 
Symptoms 
Although not a preliminary aim in the current study, there were large effect sizes for 
decreased negative symptoms in the OT group as compared to the PL group at 6 weeks. This 
is consistent with previous research in the area (e.g., Bakharev et al. 1986; Fiefel et al., 2011; 
Pedersen et al., 2011). Conversely, the PL group showed an increase (albeit non-significant) 
in negative symptoms. These results are especially intriguing in that greater negative 
symptoms are strongly related to decreased social functioning in schizophrenia (Mancuso et 
al., 2011) and quality of life (Fujimaki et al. 2012). In addition, current antipsychotics do not 
significantly ameliorate negative symptoms (Bellack et al., 2004).  
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Although reductions in total, positive, and general symptoms were also found for the 
OT group, similar reductions were observed in the placebo group. A closer look at the 
compliance data reveals that compliance was significantly correlated to change in general 
symptom scores for the OT group and a trend correlation with total PANSS scores; 
compliance was not related to symptom scores for the PL condition. Thus, greater 
compliance was associated with a larger reduction in total PANSS and general symptoms; 
again, underscoring the importance of assessing OT compliance and analyzing its 
relationship to treatment outcome.  
Limitations 
A major limitation of the current study is sample size.  The small sample size 
precluded making definitive conclusions about the effects of OT treatment on social 
cognition in schizophrenia. Similarly, the sample size did not permit exploration of variables 
that may be related to treatments effects (e.g., subgroups of individuals who show greater 
benefits from OT). However, the sample size in the current study is similar to the other OT 
schizophrenia treatment trials that have found significant OT treatment gains [Feifel at al., 
2010 (n=15); Goldman et al., 2011 (n=13)].   Regardless, larger sample sizes are needed to 
further characterize the effects of OT on social cognition. 
The current study did not include a thorough evaluation of potential OT mediators, 
such as neurocognition and anxiety.  Neurocognition was only assessed in a portion of the 
participants and so it is unknown whether OT influenced neurocognition in the current study. 
Since other research has show OT is related to improved neurocognition (MacDonald & 
MacDonald, 2010), further research in this area is warranted. Surprisingly, anxiety as 
measured by the Liebowitz Social Anxiety Scale (LSAS) and PANSS-anxiety item did not 
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significantly change in the OT condition. The anxiolytic effects of OT are well documented 
(Lee et al., 2010).  Many other studies evaluating anxiety, though, have used more objective 
and biological measures (e.g., cortisol levels); it is possible that the LSAS and the PANSS 
anxiety item were not sensitive to treatment effects. Additionally, as noted previously, 
individuals with schizophrenia have trouble accurately identifying emotional states (Dernt et 
al., 2009).  Perhaps more general measures of anxiety may be appropriate (e.g., the Beck 
Anxiety Inventory or an evaluation of cortisol levels), since the LSAS focuses on social 
anxiety, and the PANSS-anxiety item is limited in that it is a single score of anxiety (rated 
zero to seven).  It is prudent for future research to use valid and appropriate measures of 
anxiety to further investigate whether the anxiolytic effects of OT mediate improvements on 
social cognition in schizophrenia.  
The moderating effects of gender could not be explored due to only having three 
females in the current study. Other OT treatment trials have similarly recruited mostly males 
(e.g. Feifel et al., 2010).   One reason for the difficulty in recruiting females may be related to 
this study’s inclusion and exclusion criteria. Participants must have had social difficulties 
(determined by scores on the socially-relevant PANSS items and/or performance on the Eyes 
Test) to be included in the study. Reviews find that females with severe mental illness exhibit 
less social impairment as compared to men with severe mental illness (Scott, 2011); 
therefore, females were less likely to meet the inclusion criteria of the study.  While it is 
possible that men with schizophrenia have a greater need for treatments targeting social 
cognition, future research should consider exploring this variable further.  
Another limitation concerns compliance. Compliance was related to performance on a 
variety of measures in the current study and therefore future research must pay careful 
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attention to this issue. Although efforts were made to maintain compliance in the current 
study (e.g., reminder calls), compliance was still not 100 percent.  Medication compliance is 
a documented problem in schizophrenia (Moritz et al., 2012), so it is not surprising that it 
would be a consideration for OT treatment.  Other approaches to improve compliance, such 
as daily diary logs may be helpful in alleviating this issue.   
An additional limitation is that no follow up data were obtained. It is unclear whether 
treatment effects persist when the treatment has ended and how long these effects last. 
Follow-up data could also provide information as to whether effects generalize to other areas 
(e.g., service utilization, therapeutic alliance). Other OT treatment trials in schizophrenia 
have similarly not included follow-up (e.g., Feifel et al., 2011), so it is critical for future 
studies to include follow-up visits in their designs to more thoroughly characterize the effects 
of OT on social cognition.  
Lastly, the IRI self-report measure of empathy is intended to be a trait measure 
(Davis, 1983).  In the current study, participants were prompted to focus on their current 
empathic tendencies in order to try and assess state rather than trait empathy (i.e., participants 
were asked to respond to the questions using the last month as a timeframe).  Although the 
IRI is intended to be a trait measure, other studies have found treatment effects using the IRI; 
for example, Sands, et al. (2008) administered the IRI to assess the efficacy of a training 
program designed to improve empathy in health-care providers. Interestingly, they found 
increased perspective-taking on the IRI in the providers who received the training. The Sands 
et al. (2008) study suggests that the IRI is sensitive to treatment effects even-though it is 
intended to be a trait measure.  In addition, the IRI demonstrated poor internal consistency on 
two of the subscales (Perspective Taking and Distress) in the current study. Although this 
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measure has been widely used in schizophrenia research, surprisingly its psychometric 
properties have not been examined in this population. Therefore, it is critical to evaluate the 
validity and reliability of the IRI in schizophrenia samples and to assess empathy using 
measures with established psychometric properties.  
Conclusions 
Overall, the results of the current study suggest that OT improves specific aspects of 
social cognition, such as cognitive ToM, cognitive empathy, recognition of high intensity 
emotional stimuli, as well as global social skills and negative symptoms in schizophrenia. 
While these findings are preliminary, they indicate that OT may be a potential treatment for 
social functioning difficulties in schizophrenia or as an adjunctive treatment with 
psychosocial approaches.  An additional point worth noting is that OT appears to be well-
tolerated; compliance rates were similar between the OT and PL groups and there were no 
significant adverse events related to OT reported in the current study.  
The verdict is still out on OT’s mechanism of change.  Bartz et al.’s (2011) recent 
review of OT and social cognition argues that OT is context dependent, which might explain 
the observed differential effects on social cognition. That is, Bartz et al.’s review found that 
63% of the studies reviewed showed individual and situational moderating effects of OT and 
43% showed no main effect of OT.  Bartz et al. argue that contextual factors, such as the 
social salience of stimuli, likely moderate the impact of OT. Therefore, it is strongly 
recommended that individual and context specific factors be accounted for in future studies. 
Such factors include evaluating those who would most benefit from OT treatment.  
!  
 
   +-
!
In sum, this study indicates that OT may lead to improved social cognition and social 
functioning in schizophrenia; more research, however, is needed to better understand the 
magnitude and extent of its effects. While social functioning difficulties are not unique to 
schizophrenia, they are markedly compromised in this population (Mausbach et al., 2010), 
and linked to outcome (Niendam et al., 2009).  OT has the potential to improve important 
social processes in schizophrenia and thereby the quality of life of those affected and their 
families. 
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Table 8  
Correlations between compliance and 6 week-change scores on social cognitive, self-report 
measures, and symptoms 
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0A,
$5",-'/<"9,
:V,
$,5",-'/<"9,
?$+*'/,C$%4*3*-",,
ER-40 -.02(.961) -.71(.03)a 
Eyes Test .25(.510) .26(.495) 
Brune Total .41 (.270) -.06(.884) 
Trust Overall -.33 (.385) .19(.633) 
IRI total -.17(.722) -.24(.56) 
AIHQ-Agg -.40(.286) -.09(.815) 
AIHQ-Blame -.80 (.010)a -.31(.415) 
AIHQ-Host -.27(.479) -.12(.753) 
Social & Community  
Functioning  
SLOF-Soc (P) .02(.977) -.65(.234) 
SLOF-Tot (P) -.46 (.434) -.42(.482) 
SLOF-Soc (I) -.36(.555) -.12(.854) 
SLOF-Tot (I) -.61(.274) -.02(.97) 
Symptoms 
PANSS-Total -.59(.096) -.17(.672) 
Positive -.37(.331) -.52(.15) 
General -.71(.034)a -.21(.594) 
Negative .002(.997) .20(.602) 
Anxiety Item -.49(.18) -.16(.67) 
Liebowitz  .18(.636) -.08(.845) 
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Table 9!
 
 Correlations between compliance and 6 week-change scores on role-play measures 
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TELEPHONE SCREEN FOR POTENTIAL PARTICIPANTS (6 WEEK TRIAL) 
 
“HI, I’M (STATE NAME) AND I’M CALLING ABOUT A RESEARCH STUDY BEING CONDUCTED AT 
UNC CALLED OXYTOCIN TREATMENT OF SOCIAL DEFICITS AND PARANOIA IN 
SCHIZOPHRENIA.  I’M A RESEARCH ASSISTANT WORKING WITH DRS. PEDERSEN AND PENN IN 
THE PSYCHIATRY AND PSYCHOLOGY DEPARTMENTS.  YOU CALLED (OR HAVE PARTICIPATED 
IN PAST STUDIES WITH US AND HAVE AGREED TO BE CONTACTED ABOUT FUTURE STUDIES 
OR EXPRESSED INTEREST TO YOUR CARE PROVIDER). I’M FOLLOWING UP TO DESCRIBE THE 
STUDY, SEE IF YOU ARE STILL INTERESTED IN PARTICIPATING AND TO ANSWER ANY 
QUESTIONS THAT YOU MAY HAVE ABOUT THE STUDY. I WILLALSO ASK YOU SOME 
QUESTIONS TO SEE IF YOU ARE ELIGIBILE FOR THE STUDY.  THIS SHOULD ONLY TAKE ABOUT 
5-10 MINUTES.  THESE QUESTIONS WILL ASK ABOUT ANY SYMPTOMS OR EMOTIONAL 
DIFFICULTIES YOU HAD IN THE PAST OR RECENTLY.   PLEASE NOTE THAT RESPONDING TO 
THESE QUESTIONS IS TOTALLY VOLUNTARY.  ALSO, ALL INFORMATION WILL BE KEPT 
STRICTLY CONFIDENTIAL.  FINALLY, ONCE YOUR ELIGIBILITY IS DETERMINED, THIS FORM 
AND ANY INFORMATION OBTAINED FROM IT WILL BE DESTROYED. 
 
I’D LIKE TO GET SOME GENERAL INFORMATION.  FIRST, I’LL NEED YOUR NAME, AGE, ETC 
 
Name: ______________________________________    Age:_________   (Note: inclusion criteria 
is 18-55 years of age)   
 
Gender: M    F  Ethnicity:  ________   Where do you live_____________?             
 
Would you prefer to be tested at: _______UNC Hospitals in Chapel Hill or   ______Central 
Regional Hospital in Raleigh (Dorothea Dix)  
 
2.  HOW DID YOU HEAR ABOUT THE STUDY? (Check correct answer) 
 
From care provider _____ Flyer_____ Previous research participant ___________    
Other______ 
 
STUDY DESCRIPTION 
 
“NOW I’LL TELL YOU A LITTLE MORE ABOUT THE STUDY.  THIS IS A STUDY TO SEE WHETHER 
TREATMENT WITH OXYTOCIN CAN IMPROVE SOCIAL SKILLS AND REDUCE SYMPTOMS LIKE 
PARANOIA IN INDIVIDUALS WITH SCHIZOPHRENIA. OXYTOCIN IS MADE NATURALLY IN THE 
BRAIN AND SEEMS TO INCREASE TRUST AND ACCURATE READING OF OTHERS’ EMOTIONS 
AND TO DECREASE ANXIETY IN PEOPLE. 
IF YOU TAKE PART IN THIS STUDY, YOU WILL BE INVOLVED FOR APPROXIMATELY 8 WEEKS. 
YOU WILL UNDERGO A SERIES OF 6 STUDY VISITS. THE STUDY VISITS LAST BETWEEN 2 AND 
3.5 HOURS. THE STUDY VISITS ARE AT AN OUTPATIENT RESEARCH CLINIC (AT UNC IN 
CHAPEL HILL OR DOROTHEA DIX HOSPITAL IN RALEIGH, NOW CALLED CENTRAL REGIONAL 
HOSPITAL) AND YOU WILL COMPLETE SOME INTERVIEWS, QUESTIONNAIRES AND OTHER 
TASKS. AT THE END OF THE SECOND VISIT, YOU WILL TAKE YOUR FIRST TEST DOSE AND 
BEGIN A 6 WEEK TREATMENT PERIOD DURING WHICH YOU WILL TAKE EITHER OXTOCIN OR 
!  
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PLACEBO IN A NASAL SPRAY TWICE DAILY. HALF OF THE PEOPLE IN THIS STUDY WILL BE 
RANDOMLY CHOSEN TO RECEIVE OXYTOCIN AS THE NASAL SPRAY SUBSTANCE AND THE 
OTHER HALF WILL RECEIVE A NASAL SPRAY THAT HAS THE SAME INGREDIENTS AS THE 
OXYTOCIN SPRAY EXCEPT FOR THE OXYTOCIN (THIS IS CALLED A PLACEBO). IN THIS STUDY 
NEITHER YOU NOR ANY OF THE RESEARCH STAFF WHO MEET WITH YOU WILL KNOW 
WHETHER YOU ARE RECEIVING OXYTOCIN OR PLACEBO. NURSES WILL TEACH YOU HOW TO 
GIVE YOURSELF INTRANASAL SPRAY TREATMENTS SO THAT YOU FEEL COMFORTABLE 
DOING IT YOURSELF 
  YOU WILL RECEIVE A TOTAL OF $200 FOR COMPLETION OF THE ENTIRE STUDY. YOU CAN 
CHOOSE TO RECEIVE THIS EITHER BY CHECK OR BY WALMART GIFT CARDS. IF YOU DO NOT 
COMPLETE THE ENTIRE STUDY, YOU WILL BE PAID FOR THE STUDY VISITS YOU DID 
COMPLETE. DO YOU HAVE ANY QUESTIONS FOR ME ABOUT THIS STUDY?” 
 
CLINICAL QUESTIONS 
 
“NOW I’M GOING TO ASK YOU SOME PERSONAL QUESTIONS REGARDING YOUR 
PSYCHIATRIC HISTORY AND SOCIAL FUNCTIONING.  ANSWERING THESE 
QUESTIONS IS VOLUNTARY, BUT THEY WILL HELP US TO DETERMINE YOUR 
ELIGIBILITY FOR THE STUDY”. 
 
NOTE: POSSIBLE EXCLUSION ITEMS ARE IN BOLD PRINT.  PLEASE REVIEW 
ALL PHONE SCREENS WITH DR. PEDERSEN 
 
1. Has your doctor given you a diagnosis of schizophrenia? 
NO    YES 
 
2. Has there been any time in the last year that you had five or more drinks (beer, wine, 
liquor) on one occasion? 
NO YES 
-Explain: 
 
2. Have you used street drugs in the last year (and if yes which drugs, how much and how         
recently?)   
 NO YES 
-Explain: 
 
4. Have you been “hooked” on a prescribed medicine or taken more of it than you were 
supposed to during the last year? 
NO YES 
-Explain: 
 
5.       Do you have any serious medical conditions? (If yes, explain) 
 NO  YES 
 -Explain:  
 
6.        Have you had major surgery or were you seriously injured in the past year? (If yes,  
       explain) 
 NO  YES 
!  
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 -Explain 
 
7.      Are you unable or unwilling to give yourself intranasal spray treatments on a daily 
basis?  
No Yes 
 
8.   (For women) Are you pregnant, breast-feeding now or were breast feeding in the past 
three months, or did you give birth during the past six months? 
 NO  YES 
 
9. Do you often find it difficult to talk to people or feel comfortable around them? 
 NO YES 
 -Explain: 
 
10. How often will you start a conversation at home, (or if you live alone, with friends or 
acquaintances)?  
  Almost Never    0 
  Rarely                 1 
  Sometimes    2 
  Often     3 
 
11. How do you react to the presence of strangers? 
                    Avoid them    0 
  Feel nervous    1 
   Accept them    2 
   Like them    3 
 
12. How often are you able to carry on a conversation when someone starts talking to you? 
   Almost never    0 
   Rarely     1 
   Sometimes    2 
   Often     3 
13. How easy or difficult do you find it talking to people at the moment? 
  Very difficult    0 
  Quite difficult    1 
  Average    2 
  Quite easy    3 
  Very easy    4 
 
“THANK YOU FOR YOUR TIME.  I WILL SHARE THIS INFORMATION WITH DR. PEDERSEN AND 
HE OR HIS STUDY COORDINATOR WILL GET BACK TO YOU WITHIN THE NEXT FEW DAYS TO 
LET YOU KNOW ABOUT YOUR ELIGIBILITY FOR THE STUDY.  MAY I HAVE A PHONE NUMBER 
WHERE YOU CAN BE REACHED DURING THE DAYTIME AND EVENING?  MAY I LEAVE A 
MESSAGE AT THESE NUMBERS?  DO YOU HAVE AN EMAIL ADDRESS?  MAY I CONTACT YOU 
THAT WAY? DO YOU HAVE ANY QUESTIONS?” 
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TELEPHONE SCREEN FOR POTENTIAL PARTICIPANTS (12 WEEK TRIAL) 
 
“Hi, I’m (state name) and I’m calling about a research study being conducted at UNC called: 
Oxytocin treatment of social cognitive and functional deficits in schizophrenia. I’m a 
research assistant working with Drs. Pedersen and Penn in the psychiatry and psychology 
departments.  You called (or have participated in past studies with us and have agreed to be 
contacted about future studies or expressed interest to your care provider). I’m following up 
to describe the study, see if you are still interested in participating and to answer any 
questions that you may have about the study. I will also ask you some questions to see if you 
are eligible for the study.  This should only take about 5-10 minutes.  These questions will 
ask about any symptoms or emotional difficulties you had in the past or recently.   Please 
note that responding to these questions is totally voluntary.  Also, all information will be kept 
strictly confidential.   
 
I’d like to get some general information.  First, I’ll need your name, age, etc. 
 
Name: ____________________Age:_________   (Note: inclusion criteria is 18-65 years of age)   
 
Gender: M    F Date of Birth: _____________ Ethnicity:  ________   
  
Where do you live_____________?             
 
Would you prefer to be tested at: _______UNC Hospitals in Chapel Hill or   ______Central 
Regional Hospital in Raleigh (Dorothea Dix)  
 
How did you hear about the study? (Check correct answer) 
 
From care provider _____ Flyer_____ Previous research participant ___________    
Other______ 
 
STUDY DESCRIPTION 
 
“Now I’ll tell you a little more about the study.  This is a study to see whether treatment with 
oxytocin can improve social skills and reduce symptoms like paranoia in individuals with 
schizophrenia. Oxytocin is made naturally in the brain and seems to increase trust and 
accurate reading of others’ emotions and to decrease anxiety in people. 
If you take part in this study, you will be involved for approximately 14 weeks. You will 
undergo a series of 6 study visits. The study visits last between 2 and 5 hours. The study 
visits are at an outpatient research clinic (at UNC in Chapel Hill or the outpatient clinic at 
Central Regional Hospital in Raleigh) and you will complete some interviews, questionnaires 
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and other tasks. At the end of the second visit, you will take your first test dose and begin a 
12 week treatment period during which you will take either oxytocin or placebo in a nasal 
spray twice daily. Half of the people in this study will be randomly chosen to receive 
oxytocin as the nasal spray substance and the other half will receive a nasal spray that has the 
same ingredients as the oxytocin spray except for the oxytocin (this is called a placebo). In 
this study, neither you nor!any of the research staff who meet with you will know whether 
you are receiving oxytocin or placebo. Nurses will teach you how to give yourself intranasal 
spray treatments so that you feel comfortable doing it yourself. 
You will receive a total of $220 for completion of the entire study. If you do not complete the 
entire study, you will be paid for the study visits you did complete. 
 
Do you have any questions for me about this study?” 
 
CLINICAL QUESTIONS 
 
“Now I’m going to ask you some personal questions regarding your psychiatric history and social 
functioning.  Answering these questions is voluntary, but they will help us to determine your 
eligibility for the study”. 
 
NOTE: POSSIBLE EXCLUSION ITEMS ARE IN BOLD PRINT.  PLEASE REVIEW 
ALL PHONE SCREENS WITH DR. PEDERSEN. 
 
3. Has your doctor given you a diagnosis of schizophrenia or schizoaffective disorder? 
NO    YES 
 
2. Has there been any time in the last year that you had five or more drinks (beer, wine, 
liquor) on one occasion? 
NO YES 
-Explain: 
 
3. Have you used street drugs in the last year (and if yes which drugs, how much and how 
recently?)   
 NO YES 
-Explain: 
 
4. Have you been “hooked” on a prescribed medicine or taken more of it than you were 
supposed to during the last year? 
NO YES 
-Explain: 
 
8.       Do you have any serious medical conditions? (If yes, explain) 
 NO  YES 
 -Explain:  
 
9.        Have you had major surgery or were you seriously injured in the past four months? 
(If yes, explain) 
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 NO  YES 
 -Explain 
 
10.      Are you unable or unwilling to give yourself intranasal spray treatments on a daily 
basis?  
No Yes 
 
8.   (For women) Are you pregnant, breast-feeding now or were breast feeding in the past 
three months, or did you give birth during the past six months? 
 NO  YES 
 
9.          In general, how do you spend your time during the day?  
 
10.  Do you participate in activities with others?  
 If yes, ask: What activities?  
 
 If no, ask: Why not? 
 
I have just few more questions. 
 
11. Do you have any allergies to medications?    NO       YES 
 If yes, ask: “What are you allergic to”?   
 
12. Do you have a UNC Medical Record number?  NO        YES 
 (If NO and subject is scheduled for screening visit, be sure they obtain one) 
 
 
“Thank you for your time.  I will share this information with Dr. Pedersen and we will get back 
to you within the next few days to let you know about your eligibility for the study.  May I have a 
phone number where you can be reached during the daytime and evening?  May I leave a 
message at these numbers?  Do you have an email address?  May I contact you that way? Do you 
have any questions?” 
 
Day phone:_______________________ Leave message:  yes no 
 
Evening phone:___________________ Leave message:  yes no 
 
Cell phone:___________________  Leave message:  yes no 
 
Email address:___________________  Leave message:  yes  no 
  
Home address: __________________________________________________________ 
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Positive and Negative Symptom Scale -PANSS 
 
Instructions:  Complete the appropriate rating for dimension following the clinical interview.  
Refer to the rating manual for item definitions, descriptions of anchoring points, scoring 
procedure, and norms. 
 
Rating Key: 1 = absent   3 = mild      5 = moderately severe 7 = extremely 
severe 
  2 = minimal   4 = moderate      6 = severe 
 
Positive Scale       General Psychopathology Scale 
 
P1_____Delusions      G1_____Somatic concern 
 
P2_____Conceptual disorganization    G2_____Anxiety 
 
P3_____Hallucinatory behavior     G3_____Guilt feelings 
 
P4_____Excitement      G4_____Tension 
 
P5_____Grandiosity      G5_____Mannerisms and posturing 
 
P6_____Suspiciousness/persecution    G6_____Depression 
 
P7_____Hostility      G7_____Motor retardation 
         
G8_____Uncooperativeness 
Negative Scale        
G9_____Unusual thought content 
 
N1_____Blunted affect                G10_____Disorientation 
 
N2_____Emotional withdrawal                      G11_____Poor attention 
 
N3_____Poor rapport      G12_____Lack of judgment and 
insight 
 
N4_____Passive/apathetic social withdrawal             G13_____Disturbance of volition 
 
N5_____Difficulty in abstract thinking              G14_____Poor impulse control 
 
N6_____Lack of spontaneity and flow of conversation            G15_____Preoccupation 
 
N7_____Stereotyped thinking               G16_____Active social avoidance 
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Total: ____ 
!
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      ER-40 (Kohler, Turner, Gur, & Gur, 2004) Manual Scoring Sheet 
Instructions to read to the subject: In this test you will see some faces. Look carefully at each face and 
decide what emotion is showing.  How does this person feel?  Once you decide, say aloud the word to 
the right that best describes the emotion.  If the person isn’t showing any emotion, say “No Emotion.” 
Let’s try a practice face….  
 P. Happy Sad Anger Fear No Emotion 
!
 1. Happy Sad Anger Fear No Emotion 
 2. Happy Sad Anger Fear No Emotion 
 3. Happy Sad Anger Fear No Emotion 
 
4. Happy Sad Anger Fear No Emotion 
 5. Happy Sad Anger Fear No Emotion 
 
6. Happy Sad Anger Fear No Emotion 
 7. Happy Sad Anger Fear No Emotion 
 8. Happy Sad Anger Fear No Emotion 
 9. Happy Sad Anger Fear No Emotion 
 10. Happy Sad Anger Fear No Emotion 
 11. Happy Sad Anger Fear No Emotion 
 
12. Happy Sad Anger Fear No Emotion 
 13. Happy Sad Anger Fear No Emotion 
 14. Happy Sad Anger Fear No Emotion 
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 15. Happy Sad Anger Fear No Emotion 
 16. Happy Sad Anger Fear No Emotion 
 17. Happy Sad Anger Fear No Emotion 
 18. Happy Sad Anger Fear No Emotion 
 19. Happy Sad Anger Fear No Emotion 
 20. Happy Sad Anger Fear No Emotion 
 21. Happy Sad Anger Fear No Emotion 
 22. Happy Sad Anger Fear No Emotion 
 23. Happy Sad Anger Fear No Emotion 
 
24. Happy Sad Anger Fear No Emotion 
 25. Happy Sad Anger Fear No Emotion 
 26. Happy Sad Anger Fear No Emotion 
 27. Happy Sad Anger Fear No Emotion 
 28. Happy Sad Anger Fear No Emotion 
 29. Happy Sad Anger Fear No Emotion 
 
30. Happy Sad Anger Fear No Emotion 
 31. Happy Sad Anger Fear No Emotion 
 32. Happy Sad Anger Fear No Emotion 
 33. Happy Sad Anger Fear No Emotion 
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34. Happy Sad Anger Fear No Emotion 
 35. Happy Sad Anger Fear No Emotion 
 36. Happy Sad Anger Fear No Emotion 
 37. Happy Sad Anger Fear No Emotion 
 38. Happy Sad Anger Fear No Emotion 
 39. Happy Sad Anger Fear No Emotion 
 40. Happy Sad Anger Fear No Emotion 
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ER-40 (Kohler, Turner, Gur, & Gur, 2004): Sample stimuli, practice item 
P
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Theory of Mind - Picture Stories 
Sequencing score: 
•    1st/4th card correct  =  2 points 
each !
•    2nd/3rd card correct = 1 point 
each!
!
Questionnaire: 
1a) What does the person with the red shirt believe, the one in blue 
shirt intends to do?  
    (2nd order belief) (pointing to 2nd picture) 
Correct answer: Get apple from tree 
1b) What does the person with the red shirt expect from the person in  
blue shirt? (reciprocity)  
    (pointing to 4th picture)  
Correct: Give him part of the apple; share with him 
!
sum of points for Item 1 
(max. 8) 
1st picture story (apple tree) 
Score  
0     1 
Score  
0     1 
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sequencing time:   
Questionnaire: 
2a) What does the person with the blue shirt believe is in the bag? 
    (false belief) (pointing to 2nd picture) 
Correct: Gift, present, flower, (bug is incorrect) 
2b) What‘s in the bag? (reality) (pointing to 2nd picture)  
Correct: Wasp, bee, insect, or bug 
2c) What does the person in blue shirt believe the person in red intends to 
do?  
    (2nd order false belief) (pointing to 2nd picture) 
Correct: Give him a gift or present 
  
2d) What does the person in red assume the person with the blue shirt 
believes, regarding his (the one in red) intentions? (3rd order false belief)  
    (pointing to 2nd picture) 
Correct: Give him a gift or present 
2e) What do you think the person in the red shirt intended to do?  
    (deception) (whole story) 
Correct: Scare him, frighten him, shock him  
!
sum of points for Item 2 
(max. 11) 
- 2 - 
2nd picture story (Bug in the Sack) 
Score  
0     1 
Score  
0     1 
Score  
0     1 
Score  
0     1 
Score  
0     1 
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Questionnaire: 
3a) What does the person with the red shirt believe the others intend to do? 
(2nd order false belief) (pointing to 3rd picture)  
Correct: Play ball with him 
3b) What do the two characters want the one in red shirt to believe they 
intend to do? (cheating) (pointing to 3rd picture) 
Correct: Play ball with him or talk to him 
  
3c) What do they intend to do? (deception) (whole story) 
Correct: Take his ball or make him fall into a hole 
3d) What does the person in red shirt now think the other two characters 
intended to do?                  
    (cheating detection) (pointing to 4th picture) 
Correct: Trick him or take his ball 
!
sum of points for Item 3 
(max. 10) 
- 3 - 
3rd picture story (Steal the Ball) 
Score  
0     1 
Score  
0     1 
Score  
0     1 
Score  
0     1 
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Questionnaire: 
4a) What does the bald person think the other person intends to do?  
   (2nd order belief) (pointing to 1st picture)  
Correct: Climb over the wall or escape from prison 
  
4b) What does the bald person expect from the other person? (reciprocity)  
    (pointing to 3rd picture) 
Correct: To pull him up or to help him over the wall 
!
sum of points for Item 4 
(max. 8) 
- 4 - 
4th picture story (Over the wall) 
Score  
0     1 
Score  
0     1 
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Questionnaire: 
5a) What does the blond haired person believe is in the box?  
    (false belief) (pointing to 3rd picture)  
Correct: Gift or present 
5b) What‘s in the box? (reality) (pointing to 3rd picture) 
Correct: Scary jack in the box or scary toy (monster is also correct) 
5c) What does the blond person believe the other person intends to do?  
   (2nd order false belief) (pointing to 3rd picture) 
Correct: Give him a gift or present 
  
5d) What does the the person with the dark hair assume the blond person  
    believes, regarding his (the dark haired person) intentions?  
    (3rd order false belief) (pointing to 2nd picture)  
Correct: Give him a gift or present 
5e) What do you think the dark haired person intended to do? (deception)  
    (whole story) 
Correct: Scare him, or frighten him, or shock him 
!
sum of points for Item 5 
(max. 11) 
- 5 - 
5th picture story (Jack in the Box) 
Score  
0     1 
Score  
0     1 
Score  
0     1 
Score  
0     1 
Score  
0     1 
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Questionnaire: 
6a) What does the person in the blue shirt intends to do?  
   (intention) (pointing to 1st picture)  
Correct: Take jar or candy or toys from the store 
6b) What does the shopgirl believe has happened?  
    (false belief) (pointing to 3rd picture) 
Correct: An accident on his bike or he fell of his bike, or he is injured 
  
6c) What do the person in blue and the one in red intend to do?  
   (cheating) (pointing to 2nd picture) 
Correct: Distract her and steal her jar 
6d) What does the person in red expect from the person in blue?  
    (reciprocity) (pointing to 4th picture) 
Correct: To help him steal the jar or to share the jar with him 
6e) What does the shopgirl now think the boys intended to do?  
    (cheating detection) (pointing to 4th picture) 
Correct: Steal from her or steal the jar 
!
sum of points for Item 6 
(max. 11) 
- 6 - 
6th picture story (Bike Accident) 
Score  
0     1 
Score  
0     1 
Score  
0     1 
Score  
0     1 
Score  
0     1 
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Brune Measure (Brune 2003): Sample Stimuli 
!
!
!
!
!
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  EYES TEST (Baron-Cohen, Wheelwright, Hill, Raste, & Plumb, 2001) 
You will be seeing on the computer screen a series of 36 pictures of individuals expressing a feeling 
or emotion with their eyes.  Your task is to look at each pair of eyes and select the emotion that best 
fits the actor’s facial expression.  Please indicate your choice by stating out loud the emotion on that 
person’s face.  Once you give your answer, we will go on to the next face.  If you do not know what a 
word means, ask and a definition will be provided for you.  Please be aware that we can’t go back to 
faces you’ve seen already.  So, please make sure that your answer for each pair of eyes is a final one.  
If you are not sure of your answer, please take your best guess. 
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Eyes Test (Baron-Cohen, Wheelwright, Hill, Raste, & Plumb, 2001): Sample Stimuli, 
practice item 
 
jealous
hatefularrogant
panicked
P
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                                                  TRUSTWORTHINESS TASK (Adolphs et al., 1998) 
 “I am going to show you some pictures of faces. Just from looking at each person’s face, tell me how much you 
feel each person can be trusted. You can think of a person you really trust as someone you would trust with your 
life. You can think of a person you really don’t trust as a really big criminal. Now imagine that you were asking 
each person to hold some money for you. How comfortable would you feel with each one?If you think you 
would trust them a lot, as if you would let them hold $5,000 of yours, give them a “+3”.If you think you would 
hardly trust them at all, as if you couldn’t even trust them to keep 50 cents for you, give them a “-3”.If you 
could sort of trust them, give them a “+2”.If you would sort of not trust them, give them a “-2”.EXAMPLE: The 
first person’s face you see is right in the middle, or average on both scales. You should consider him to be a 
“0”.Now, look at this person’s face…. How much do you feel this person can be trusted…? What number would 
you give? 
 Image Subject’s  
score 
Image Subject’s  
score 
1.  # 37  22.  # 28  
2.  # 15  23.  # 21  
3.  # 27  24.  # 36  
4.  # 35  25.  # 25  
5.  # 40  26.  # 34  
6.  # 12  27.  # 16  
7.  # 33  28.  # 11  
8.  # 20  29.  # 30  
9.  # 17  30.  # 32  
10.  # 19  31.  # 29  
11.  # 6  32.  # 4  
12.  # 3  33.  # 26  
13.  # 38  34.  # 41  
14.  # 10  35.  # 24  
15.  # 14  36.  # 8  
16.  # 18  37.  # 2  
17.  # 5  38.  # 7  
18.  # 31  39.  # 13  
19.  # 1  40.  # 22  
20.  # 9  41.  # 42  
21.  # 23  42.  # 39   
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Trustworthiness Task (Adolphs et al., 1998): Sample Stimuli 
 
 
 
Average
Not at all
Trustworthy
Very
Trustworthy
0 +2+1-2 -1-3 +3
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 Ambiguous Intentions Hostility Questionnaire: AIHQ (Combs et al. 2007) 
On the next few pages there are some everyday situations that I will read to you. They will be about 
people and how they act toward you. Imagine how each situation might happen to you. For each 
situation, I will ask you for a brief reason for why it happened.  Then, I will ask you to rate whether 
you think the person acted that way toward you on purpose. I will then ask you to rate how angry that 
situation makes you feel and then how much you blame the other person.  Finally, please tell me what 
you would do about that situation.  A response of “I don’t know” is not acceptable.  You need to 
describe some type of behavioral response. 
1. You’ve been at a new job for three weeks.  One day, you see one of your new co-
workers on the street.  You start to walk up to this person and start to say hello, 
but she/he passes by you without saying hello. 
A. What do you think was the real reason why your coworker passed by you without 
saying hello?  
 
B. Do you think your coworker did this to you on purpose? 
 
 
C. H
ow 
angr
y would this make you feel? 
 
1 
Not at 
All Angry 
2 3 4 5 
Very 
Angry 
 
D. How much would you blame the coworker for passing by you? 
 
1 
Not at 
All  
2 3 4 5 
Very 
Much 
 
E. What would you do about it? 
1 
Definitely 
No 
2 
Probably 
No 
3 
Maybe 
No 
4 
Maybe  
Yes 
5  
Probably 
Yes 
6 
Definitely 
Yes 
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2. You have an appointment with an important person.  When you arrive at your 
appointment, the secretary informs you that the person is not in; they took the 
day off. 
 
A. What do you think was the real reason why the person didn’t keep the 
appointment?  
 
B. Do you think the person did this to you on purpose? 
 
 
 
C. H
ow 
angr
y would this make you feel? 
 
1 
Not at 
All Angry 
2 3 4 5 
Very 
Angry 
 
D. How much would you blame the person for not keeping your appointment? 
 
1 
Not at 
All  
2 3 4 5 
Very 
Much 
 
E. What would you do about it? 
_____________________________________________________ 
1 
Definitely 
No 
2 
Probably 
No 
3 
Maybe 
No 
4 
Maybe  
Yes 
5  
Probably 
Yes 
6 
Definitely 
Yes 
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3. You walk past a bunch of teenagers at a mall and you hear them start to laugh. 
 
A. What do you think was the real reason why the teenagers started to laugh after 
you walked past them?  
 
B. Do you think the teenagers did this to you on purpose? 
 
 
 
C. H
ow 
angr
y would this make you feel? 
 
1 
Not at 
All Angry 
2 3 4 5 
Very 
Angry 
 
D. How much would you blame the teenagers for laughing as you walked past 
them? 
 
1 
Not at 
All  
2 3 4 5 
Very 
Much 
 
E. What would you do about it? 
1 
Definitely 
No 
2 
Probably 
No 
3 
Maybe 
No 
4 
Maybe  
Yes 
5  
Probably 
Yes 
6 
Definitely 
Yes 
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4. You are supposed to meet a new friend for lunch at a restaurant but she/he 
never shows up. 
 
A. What do you think was the real reason why your new friend didn’t show up at 
the restaurant?  
B. Do you think your new friend did this to you on purpose? 
 
 
C. H
ow 
angr
y 
wou
ld this make you feel? 
 
1 
Not at 
All Angry 
2 3 4 5 
Very 
Angry 
 
D. How much would you blame your new friend for not showing up at the 
restaurant? 
 
1 
Not at 
All  
2 3 4 5 
Very 
Much 
 
1 
Definitely 
No 
2 
Probably 
No 
3 
Maybe 
No 
4 
Maybe  
Yes 
5  
Probably 
Yes 
6 
Definitely 
Yes 
!  
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E. What would you do about it? 
5. You call a friend and leave a message on their answering machine, asking them 
to call you back.  One week passes and they have not called you back. 
 
A. What do you think was the real reason why your friend didn’t call you back? 
 
B. Did your friend not call you back on purpose? 
 
 
 
C. H
ow 
angr
y would this make you feel? 
 
1 
Not at 
All Angry 
2 3 4 5 
Very 
Angry 
 
D. How much would you blame your friend for not calling you back? 
 
1 
Not at 
All  
2 3 4 5 
Very 
Much 
 
E. What would you do about it? 
1 
Definitely 
No 
2 
Probably 
No 
3 
Maybe 
No 
4 
Maybe  
Yes 
5  
Probably 
Yes 
6 
Definitely 
Yes 
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                    IRI: Interpersonal Reactivity Index (Davis, 1983).  
 
The following statements inquire about your thoughts and feelings in a variety of situations.  For each item, 
indicate how well it describes you by choosing the appropriate number on the scale at the top of the page: 1, 2, 
3, 4, or 5. When you have decided on your answer, fill in the number on the answer sheet next to the item 
number. READ EACH ITEM CAREFULLY BEFORE RESPONDING.  Answer as honestly as you can. Thank 
you. 
 
ANSWER SCALE: 
1 2 3 4 5 
Does not 
describe me well 
   Describes me 
very well 
 
1. I daydream and fantasize, with some regularity, about things that might   _____ 
happen to me. 
2. I often have tender, concerned feelings for people less fortunate than me.  _____ 
3. I sometimes find it difficult to see things from the “other guy’s” point of view. _____ 
4. Sometimes I don’t feel very sorry for other people when they are    _____ 
having problems. 
5. I really get involved with the feelings of the characters in a novel.   _____ 
6. In emergency situations, I feel apprehensive and ill-at-ease.    _____ 
7. I am usually objective when I watch a movie or play, and I don’t often get   _____ 
completely caught up in it. 
8. I try to look at everybody’s side of a disagreement before I make a decision.   _____ 
9. When I see someone being taken advantage of, I feel kind of protective  _____ 
towards them. 
10. I sometimes feel helpless when I am in the middle of a very emotional situation. _____ 
11. I sometimes try to understand my friends better by imagining how things   _____ 
look from their perspective. 
12. Becoming extremely involved in a good book or movie is somewhat rare for me. _____ 
13. When I see someone get hurt, I tend to remain calm.     _____ 
!  
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14. Other people’s misfortunes do not usually disturb me a great deal.   _____ 
15. If I’m sure I’m right about something, I don’t waste much time    _____ 
listening to other people’s arguments. 
16. After seeing a play or movie, I have felt as though I were one of the characters. _____ 
17. Being in a tense emotional situation scares me.     _____ 
18. When I see someone being treated unfairly, I sometimes don’t feel very much  _____ 
pity for them. 
19. I am usually pretty effective in dealing with emergencies.    _____ 
20. I am often quite touched by things that I see happen.     _____ 
21. I believe that there are two sides to every question and try to look at them both. _____ 
22. I would describe myself as a pretty soft-hearted person.    _____ 
23. When I watch a good movie, I can very easily put myself in the place of a   _____ 
leading character.  
24. I tend to lose control during emergencies.      _____ 
25. When I’m upset at someone, I usually try to “put myself in his shoes” for a while. _____ 
26. When I am reading an interesting story or novel, I imagine how I would feel   _____ 
if the events in the story were happening to me. 
27. When I see someone who badly needs help in an emergency, I go to pieces.  _____ 
28. Before criticizing somebody, I try to imagine how I would feel if I were   _____ 
in their place. 
!
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Social Skill and Empathy Rating Sheet for Role-Plays 
Content – the appropriateness (or strangeness) of the conversational content 
1 2 3 4 5 
Discussed bizarre or 
inappropriate topics 
The content seems 
strange and slightly 
off; may provide 
odd answers to 
questions 
Presence of one or 
two strange 
statements, but on 
the whole the 
conversation is 
appropriate 
Content is 
appropriate and fits 
context 
Content is very 
pleasant and 
appropriate to the 
topic 
 
Clarity – clear enunciation of speech, includes the amount of verbal slurring and mumbling, volume 
of speech, and difficulty in understanding speech
 
1 2 3 4 5 
Slurring or 
mumbling makes 
the participant 
barely 
understandable 
Some slurring or 
mumbling and has 
an impact on 
understanding the 
person 
Average 
slurring/mumbling 
but does not impact 
ability to understand 
Rare slurring or 
mumbling 
Speech is 
exceptionally clear 
and easily 
understood 
 
Fluency – smoothness of verbal speech (includes stuttering, pauses, or other interruptions in their own 
speech such as using “um” or other fillers
 
1 2 3 4 5 
Multiple pauses and 
interruptions 
negatively impact 
the conversation 
Pauses and 
interruptions have a 
minimal impact on 
conversation 
Pauses and 
interruptions are 
easily noticeable 
but do not interfere 
Pauses and 
interruptions are 
only slightly 
noticeable 
No pauses or 
interruptions 
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Meshing – the smoothness of turn taking during the conversation, includes interrupting the other 
person or long pauses before responding to them, also lulls in the conversation  
   
1 2 3 4 5 
Continually 
interrupts or does 
not speak following 
the confederate, 
making the 
conversation forced 
and severely 
impacts the 
conversation 
Some pauses or 
interruptions that 
are noticeable and 
make the 
conversation seem 
halting or stilted 
resulting in a 
negative impact on 
the conversation 
Some pauses and 
interruptions but 
appear normal and 
do not impact the 
conversation 
Conversation flows 
well but there are 
some barely 
noticeable pauses 
and interruptions 
Smooth 
conversation 
without 
interruptions, 
pauses.  
 
Gaze – frequency, duration, and appropriateness of eye contact 
1 2 3 4 5 
Completely avoids 
eye contact  
Eye contact is 
sporadic and brief 
Eye contact is made 
occasionally, but is 
apparent 
Eye contact occurs 
often but is short in 
duration 
Eye contact is 
natural and has 
good duration 
 
Involvement – the extent to which they appear involved in the conversation; includes verbal and non-
verbal gestures, such as volunteering information and nodding; as well as uninvolved behaviors such 
as looking away, and checking a watch 
1 2 3 4 5 
Appears 
disinterested due to 
short answers, 
infrequent nodding 
and not asking 
questions; lack of 
participant effort.  
Listens and may 
nod, but does not 
ask questions or 
volunteer 
information and 
seems to put forth 
little effort 
Listens and nods 
and openly offers 
information, but 
makes no attempt to 
engage the 
confederate (e.g. by 
asking questions)  
Listens attentively, 
nods and answers 
questions, asks 
questions 
Highly involved in 
the conversation 
and engaged; 
appears to enjoy the 
conversation  
 
Asks Questions – number of questions asked by the participant 
1 2 3 4 5 
Asks one or no Asks two questions Asks three Asks four questions Asks five or more 
!  
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questions questions 
 
  
 
Appropriate Affect – communication of feeling through facial expression, use of gestures and vocal 
tone that is consistent with the content of the speech and with other forms of emotional expression. 
1 2 3 4 5 
Inappropriate affect 
(e.g., smiling during 
sad content) 
Emotional 
expression is 
somewhat 
inconsistent with 
the topic 
Emotional 
expression is 
appropriate but 
slightly out of place 
(e.g., extreme anger 
about something 
only slightly 
upsetting) 
Emotional 
expression is 
appropriate 
Emotional 
expression enhances 
the conversation 
Flat Affect – amount of communication of feeling through facial expression, use of gestures and 
vocal tone 
1 2 3 4 5 
No emotion is 
displayed 
Expression of 
emotion are 
infrequent and 
appear to be stilted, 
forced, or lacking 
modulation 
Moderate amounts 
of emotions 
displayed 
Emotional 
expression appears 
natural and a range 
of emotions are 
apparent 
Feelings are 
communicated freely 
and frequently 
Social Anxiety – the amount of anxiety displayed by the participant during the conversation, 
evidenced by shaking, voice wavering, sweating, stuttering, squirming, etc. 
1 2 3 4 5 
Extremely 
anxious—stuttering, 
playing with their 
hands and 
negatively impacts 
the conversation 
Anxiety is clear and 
negatively impacts 
the conversation 
Some anxiety but 
has limited impact 
on conversation 
Very little anxiety, 
conversation goes 
smoothly 
No anxiety 
apparent; seems at 
ease 
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Overall Social Skill – the person’s level of social skill, includes how easy it would be to talk to them, 
their ability to interact in a meaningful way, and whether or not you would feel comfortable talking to 
them.  Take into account all of your previous ratings, and use this as a “summary” score. 
1 2 3 4 5 
Extremely poor Poor Neither skilled nor 
unsilled 
Good Extremely skilled 
 
 
FOLLOWING RATINGS ARE ONLY APPLICABLE TO SCENARIO 2 (ASKING FOR HELP 
ROLE-PLAYS 
Emotional Empathy-- To what extent does the participant share the emotional experience of 
the confederate such that they communicate they notice the confederate is not happy and 
demonstrate concern; For example they may lower their tone of voice and note “I am sorry 
this happened to you.”  
 
1 2 3 4 5 
No emotions 
shared; appears not 
to connect 
emotionally and 
does not 
demonstrate 
concern (e.g. never 
asks what is wrong) 
Does not appear to 
share the emotional 
experience of the 
confederate, but 
does not appear 
distant and may ask 
what is wrong  
Emotional 
experience is 
shared, but is 
verbally and 
visually limited; 
e.g, they ask how 
the participant is 
doing but doing 
Demonstrate 
concern by asking 
how they are doing 
and with non-verbal 
gestures (tone of 
voice, facial 
expression) 
Communicates 
concern throughout 
the role-play, 
providing multiple 
examples of 
emotional empathy.  
 
Cognitive Empathy--To what extent does the participant understand what the confederate 
must be feeling about the situation. Do them seem to be able to put themselves in the other 
person’s shoes? For instance, the participant may reflect back how the confederate feels (e.g., 
“You feel sad because your friend did not come”). The participant may also indicate they 
would feel similarly if the situation happened to them (e.g., “I would be sad if my friend did 
not show”).   
 
1 2 3 4 5 
No indication or 
attempt to 
understand how the 
confederate must be 
feeling  
Does not appear to 
understand how the 
confederate is 
feeling (e.g., does 
not provide 
examples they have 
felt similarly), but 
Some indication 
they know how the 
confederate is 
feeling; e.g., may 
give one reflection 
or one example of a 
time they felt 
Indicates they 
understand how the 
confederate is 
feeling 
Verbalizes that they 
understand what the 
confederate is 
feeling such that it 
enhances the 
conversation 
!  
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does not appear 
distant 
similarly.  
Ideomotoric Empathy---The extent that the participant’s body language matches the 
confederate. This may apply to the body (e.g., matching body posture) or face (e.g., sharing a 
similar facial expression as the confederate).  
 
1 2 3 4 5 
No matching body 
or  facial expression 
and has a negative 
impact on 
conversation 
Minimal matching 
of body language 
or facial expression 
Occasional 
matching of body 
language and/or 
facial expression 
Matching of body 
language and/or 
facial expression 
for most of the 
role-play.  
Naturally matches 
body language 
and/or facial 
expression 
throughout the entire 
role-play such that it 
communicates 
understanding and 
empathy 
 
Helpfulness – How helpful the participant is during the second role-play. Helpfulness is indexed by 
offering solutions and/or demonstrating reassurance (e.g., “Everything is going to work itself out.”) 
1 2 3 4 5 
Not helpful; does 
not offer any advice 
or suggestions or 
makes suggestions 
that are unhelpful to 
the confederate; has 
negative impact on 
the conversation 
Does not offer any 
suggestions or show 
reassurance.  
May makes one 
suggestion or 
occasional 
reassurance 
Tries to offer two  
solutions or 
reassurance  
Offers multiple 
solutions or 
reassurance (more 
than once) 
continuously 
throughout the role-
play 
 
Overall empathy-- The person’s level of empathy, includes whether you think they communicated 
and displayed empathy. Would you describe this person as empathic?  Take into account all of your 
previous empathy ratings, and use this as a “summary” empathy score. 
1 2 3 4 5 
Unempathic and 
appears distant 
Unempathic but not 
distant 
Moderately 
empathic 
Displays adequate 
empathy 
Effectively displays 
empathy and it 
enhances the 
conversation 
!  
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Specific Levels of Functioning Scale (Schneider & Struening, 1983): Patient Questionnaire 
Instructions:  Circle the number that best describes your typical level of functioning on each 
item below.  Mark only one number for each item.  Be sure to mark all items. 
Social Functioning 
A.  Interpersonal Relationships 
Item Rating 
 Highly 
Typical  
Generally 
Typical  
Somewhat 
Typical  
Generally 
Untypical  
Highly 
Untypical  
1. Accept contact with 
others  
5 4 3 2 1 
2. Initiates contact with 
others 
5 4 3 2 1 
3. Communicates 
effectively 
5 4 3 2 1 
4. Engages in activities 
without prompting 
5 4 3 2 1 
5. Participates in groups 5 4 3 2 1 
6. Forms and maintains 
friendships 
5 4 3 2 1 
7. Asks for help when 
needed 
5 4 3 2 1 
 
B. Social Acceptability 
Item Rating 
 Never Rarely Sometimes Frequently Always 
8. Regularly argues 
with others 
5 4 3 2 1 
9. Has physical fights 
with others 
5 4 3 2 1 
10. Destroys property 5 4 3 2 1 
11. Physically abuses 
self 
5 4 3 2 1 
12. Is fearful, crying, 
clinging 
5 4 3 2 1 
!  
 
   ,&-!
!
13. Takes property from 
others without 
permission 
5 4 3 2 1 
 
Community Living Skills 
 
C.  Activities 
        
        Item 
Totally Self 
Sufficient 
Needs 
Verbal 
Advice or 
Guidance 
Needs Some 
Physical 
Help or 
Assistance 
Needs 
Substantial 
Help 
Totally 
Dependent 
14. Household responsibilities (house 
cleaning, cooking, washing 
clothes) 
5 4 3 2 1 
15. Shopping (selection of items, 
choice of stores, payment at 
register) 
5 4 3 2 1 
16. Handling personal finances 
(budgeting, paying bills) 5 4 3 2 1 
17. Use of telephone (getting 
number, dialing, speaking, 
listening) 
5 4 3 2 1 
18. Traveling from residence without 
getting lost 
5 4 3 2 1 
19. Use of public transportation 
(selecting route, using timetable, 
paying fares, making transfers) 
5 4 3 2 1 
20. Use of leisure time (reading , 
visiting friends, listening to music) 
5 4 3 2 1 
21. Recognizing and avoiding 
common dangers (traffic safety, 
fire safety)  
5 4 3 2 1 
22. Self-medication (understanding 
purpose, taking as prescribed, 
recognizing side effects) 
 
5 4 3 2 1 
23. Use of medical and other 
community services (knowing 
whom to contact, how, and when 
5 4 3 2 1 
!  
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to use) 
24. Basic reading, writing, and 
arithmetic (enough for daily 
needs) 
5 4 3 2 1 
 
D. Work Skills 
Item Rating 
 Highly 
Typical  
  
Generally 
Typical 
Somewhat 
Typical  
Generally 
Untypical  
Highly 
Untypical  
25. Has employable skills 5 4 3 2 1 
26. Works with minimal 
supervision 5 4 3 2 1 
27. Is able to sustain work 
effort (not easily 
distracted, can work 
under stress) 
5 4 3 2 1 
28. Appears at 
appointments on time 5 4 3 2 1 
29. Follows verbal 
instructions  
accurately 
5 4 3 2 1 
30. Completes assigned 
tasks 5 4 3 2 1 
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Specific Levels of Functioning Scale (Schneider & Struening, 1983): Informant Questionnaire 
Instructions:  Circle the number that best describes ____________________’s  typical level 
of functioning on each item below.  If you are not sure about a certain rating, please give 
your best guess.Mark only one number for each item.  Be sure to mark all items. 
Social Functioning 
A.  Interpersonal Relationships 
Item Rating 
 Highly 
Typical 
of This 
Person 
Generally 
Typical of 
This 
Person 
Somewhat 
Typical of 
This Person 
Generally 
Untypical of 
This 
Person 
Highly 
Untypical 
of This 
Person 
31. Accepts contact with 
others  
(does not withdraw or 
turn away) 
5 4 3 2 1 
32. Initiates contact with 
others 
5 4 3 2 1 
33. Communicates 
effectively 
(speech and gestures 
are understandable and 
to the point) 
5 4 3 2 1 
34. Engages in activities 
without prompting 
5 4 3 2 1 
35. Participates in groups 5 4 3 2 1 
36. Forms and maintains 
friendships 
5 4 3 2 1 
37. Asks for help when 
needed 
5 4 3 2 1 
 
B. Social Acceptability 
Item Rating 
 Never Rarely Sometimes Frequently Always 
38. Regularly argues 
with others 
5 4 3 2 1 
39. Has physical fights 
with others 
5 4 3 2 1 
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40. Destroys property 5 4 3 2 1 
41. Physically abuses 
self 
5 4 3 2 1 
42. Is fearful, crying, 
clinging 
5 4 3 2 1 
43. Takes property from 
others without 
permission 
5 4 3 2 1 
 
Community Living Skills 
C.  Activities 
        
        Item 
Totally Self 
Sufficient 
Needs 
Verbal 
Advice or 
Guidance 
Needs Some 
Physical 
Help or 
Assistance 
Needs 
Substantia
l Help 
Totally 
Dependent 
44. Household responsibilities (house 
cleaning, cooking, washing 
clothes) 
5 4 3 2 1 
45. Shopping (selection of items, 
choice of stores, payment at 
register) 
5 4 3 2 1 
46. Handling personal finances 
(budgeting, paying bills) 5 4 3 2 1 
47. Use of telephone (getting 
number, dialing, speaking, 
listening) 
5 4 3 2 1 
48. Traveling from residence without 
getting lost 
5 4 3 2 1 
49. Use of public transportation 
(selecting route, using timetable, 
paying fares, making transfers) 
5 4 3 2 1 
50. Use of leisure time (reading , 
visiting friends, listening to music) 
5 4 3 2 1 
51. Recognizing and avoiding 
common dangers (traffic safety, 
fire safety)  
5 4 3 2 1 
52. Self-medication (understanding 
purpose, taking as prescribed, 
recognizing side effects) 
5 4 3 2 1 
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53. Use of medical and other 
community services (knowing 
whom to contact, how, and when 
to use) 
5 4 3 2 1 
54. Basic reading, writing, and 
arithmetic (enough for daily 
needs) 
5 4 3 2 1 
 
D. Work Skills 
Item Rating 
 Highly 
Typical of 
This 
Person 
  
Generally 
Typical of 
This 
Person 
Somewhat 
Typical of 
This 
Person 
Generally 
Untypical 
of This 
Person 
Highly 
Untypical 
of This 
Person 
55. Has  employable skills 5 4 3 2 1 
56. Works with minimal 
supervision 5 4 3 2 1 
57. Is able to sustain work 
effort (not easily 
distracted, can work 
under stress) 
5 4 3 2 1 
58. Appears at 
appointments on time 5 4 3 2 1 
59. Follows verbal 
instructions  
accurately 
5 4 3 2 1 
60. Completes assigned 
tasks 5 4 3 2 1 
 
Other Information 
61. How well do you know the skills and behavior of the person you just rated? (Circle one) 
 
Very Well         Fairly Well                                 Not Very Well At All     
5   4    3                   2                          1             
!
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